var title_f30_4_30784="Vulvar squamous carcinoma";
var content_f30_4_30784=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Squamous carcinoma extending close to the clitoris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This case is suitable for anterior horseshoe modified radical vulvectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of C. William Helm, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30784=[""].join("\n");
var outline_f30_4_30784=null;
var title_f30_4_30785="Patient information: Aplastic anemia (The Basics)";
var content_f30_4_30785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?2/47/2802\">",
"         Patient information: Bone marrow transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?5/26/5537\">",
"         Patient information: Complete blood count (CBC) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?34/4/34886\">",
"         Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Aplastic anemia (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/aplastic-anemia-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H13954902\">",
"      <span class=\"h1\">",
"       What is aplastic anemia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Aplastic anemia is a condition that happens when a person has too few blood cells. There are 3 different types of blood cells:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Red blood cells &ndash; These cells carry oxygen to your body.",
"       </li>",
"       <li>",
"        White blood cells &ndash; These cells fight infections.",
"       </li>",
"       <li>",
"        Platelets &ndash; Platelets are actually pieces of cells, not whole cells. They help clots forms so that you stop bleeding after you are injured.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Blood cells are made in the middle of your bones, in a part called the bone marrow. Aplastic anemia happens when your body stops making enough of all 3 types of cells at the same time.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954917\">",
"      <span class=\"h1\">",
"       What causes aplastic anemia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Aplastic anemia is caused by damage to your bone marrow. Some people are born with damaged bone marrow. In older children or adults, many things can damage bone marrow, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Certain medicines used to treat arthritis and epilepsy",
"       </li>",
"       <li>",
"        Certain chemicals used in industry and farming",
"       </li>",
"       <li>",
"        Infections from viruses",
"       </li>",
"       <li>",
"        Problems with your body&rsquo;s infection fighting system",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      But for many people, doctors don&rsquo;t know the cause of aplastic anemia.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954932\">",
"      <span class=\"h1\">",
"       What are the symptoms of aplastic anemia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling very tired",
"       </li>",
"       <li>",
"        A fast heartbeat",
"       </li>",
"       <li>",
"        Trouble breathing when you move around",
"       </li>",
"       <li>",
"        Getting infections often",
"       </li>",
"       <li>",
"        Having more bleeding than normal from the skin, nose, or gums",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Women with aplastic anemia might bleed more than normal during their menstrual periods.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954947\">",
"      <span class=\"h1\">",
"       Is there a test for aplastic anemia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests, including a &ldquo;complete blood count&rdquo; or &ldquo;CBC&rdquo;",
"       </li>",
"       <li>",
"        Bone marrow biopsy &ndash; For this test, a doctor will take a very small sample of the bone marrow. Then another doctor will look at the cells under a microscope.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954962\">",
"      <span class=\"h1\">",
"       How is aplastic anemia treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The treatment depends on the cause of your aplastic anemia. Treatment can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Stopping medicines that caused the problem",
"       </li>",
"       <li>",
"        Staying away from toxic chemicals",
"       </li>",
"       <li>",
"        Medicines &ndash; These can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Antibiotics and anti-viral medicines",
"       </li>",
"       <li>",
"        Medicines that reduce the activity of your body&rsquo;s infection-fighting system (called &ldquo;immunosuppressive&rdquo; medicines)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood transfusion &ndash; During a blood transfusion, you will get blood that has been donated by someone else. The donated blood goes into your vein through a small tube called an &ldquo;IV.&rdquo;",
"       </li>",
"       <li>",
"        Bone marrow transplant (also called a &ldquo;stem cell transplant&rdquo;) &ndash; This procedure replaces abnormal or missing cells in the bone marrow with healthy cells from a donor. These cells are given through an &ldquo;IV.&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954977\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/47/2802?source=see_link\">",
"       Patient information: Bone marrow transplant (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/26/5537?source=see_link\">",
"       Patient information: Complete blood count (CBC) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/4/34886?source=see_link\">",
"       Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?30/4/30785?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82989 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-189.2.19.178-485ACEB782-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30785=[""].join("\n");
var outline_f30_4_30785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954902\">",
"      What is aplastic anemia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954917\">",
"      What causes aplastic anemia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954932\">",
"      What are the symptoms of aplastic anemia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954947\">",
"      Is there a test for aplastic anemia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954962\">",
"      How is aplastic anemia treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954977\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/47/2802?source=related_link\">",
"      Patient information: Bone marrow transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/4/34886?source=related_link\">",
"      Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/26/5537?source=related_link\">",
"      Patient information: Complete blood count (CBC) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_4_30786="Nasopharyngeal airway insertion";
var content_f30_4_30786=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79849&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79849&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Nasopharyngeal airway insertion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The NPA should be coated with water-soluble lubricant or anesthetic jelly. The device is then inserted along the floor of the naris into the posterior pharynx behind the tongue. Clinicians should note that the floor of the naris inclines in a caudad orientation approximately 15 degrees. The tube can be rotated slightly if resistance is encountered.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30786=[""].join("\n");
var outline_f30_4_30786=null;
var title_f30_4_30787="Malignant mesothelioma II MRI";
var content_f30_4_30787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    MRI scan, axial, T2 weighted sequence, shows pleural effusion displays high signal intensity. No chest wall invasion is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30787=[""].join("\n");
var outline_f30_4_30787=null;
var title_f30_4_30788="Monocular vision loss";
var content_f30_4_30788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64435%7EEM%2F64873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64435%7EEM%2F64873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Monocular vision loss algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 695px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     EOM: extraocular movement; IIH: idiopathic intracranial hypertension; IOP: intraocular pressure.",
"     <br>",
"      * Eccentric pupil, prolapse of uvea or other structure, decreased anterior chamber size, and/or tenting of cornea/sclera.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Injuries anterior and posterior to the lens often coexist.",
"       <br>",
"        &Delta; Causes include rapidly expanding infectious, vascular, or neoplastic masses.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Binocular vision loss algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 580px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IIH: idiopathic intracranial hypertension, ICP: intracranial pressure, CNS: central nervous system, ICI: intracranial injury.",
"     <br>",
"      * Etiologies are the same as for unilateral eye trauma.&nbsp;Go to algorithm \"Monocular vision loss\".",
"      <br>",
"       &bull; Causes include cerebral ischemia, cerebral stroke, meningoencephalitis, and uremia.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30788=[""].join("\n");
var outline_f30_4_30788=null;
var title_f30_4_30789="Mercaptopurine: Patient drug information";
var content_f30_4_30789=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mercaptopurine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/43/37559?source=see_link\">",
"     see \"Mercaptopurine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/47/15095?source=see_link\">",
"     see \"Mercaptopurine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Purinethol&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Purinethol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691666",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a type of leukemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691796",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Crohn's disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ulcerative colitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3558764",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat immune linked hepatitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702472",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mercaptopurine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697144",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a thiopurine methyltransferase deficiency, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC drugs, vitamins, natural products, or herbals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697946",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Night sweats.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424303",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11789 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-4B2100FB5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30789=[""].join("\n");
var outline_f30_4_30789=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193227\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193228\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029918\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029920\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029919\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029924\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029925\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029927\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029922\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029923\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029928\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029929\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/43/37559?source=related_link\">",
"      Mercaptopurine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/47/15095?source=related_link\">",
"      Mercaptopurine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_4_30790="Tibial shaft fractures in adults";
var content_f30_4_30790=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tibial shaft fractures in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/4/30790/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30790/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/4/30790/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30790/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/4/30790/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30790/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/4/30790/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tibial fractures are common long-bone injuries. National Center for Health Statistics cites 492,000 tibial fractures per year in the United States. Open fractures generally occur from high velocity trauma (eg, automobile collision). Closed injuries may occur from falls or sports-related trauma.",
"   </p>",
"   <p>",
"    This topic will review issues related to tibial shaft fractures. Tibial shaft fractures in children and a general overview of tibial fractures in adults are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/46/24296?source=see_link\">",
"     \"Tibial and fibular shaft fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26358?source=see_link\">",
"     \"Overview of tibial fractures in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Greater than 70,000 hospitalizations, 800,000 office visits, and 500,000 hospital days have been attributed to tibial shaft fractures in the United States annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/1\">",
"     1",
"    </a>",
"    ]. The presence of significant osteoporosis increases the risk for compound or more complex fractures with higher morbidity. In Europe, closed tibial fractures are often associated with football (soccer) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Shin guards may provide some protection, but many players who sustain tibial fractures are using shin guards at the time of injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/4\">",
"     4",
"    </a>",
"    ]. Skiing is another sport commonly associated with low-energy, often torsional, tibia fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/5\">",
"     5",
"    </a>",
"    ]. More severe tibia fractures stem from high-energy trauma, most often motor vehicle collisions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tibia is the major weight-bearing bone of the lower leg (",
"    <a class=\"graphic graphic_picture graphicRef54800 \" href=\"mobipreview.htm?41/14/42213\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef65590 \" href=\"mobipreview.htm?26/45/27349\">",
"     picture 2",
"    </a>",
"    ). The proximal portion of the bone, the tibial plateau, forms the lower surface of the knee joint. The tibial shaft bridges the distance to the distal tibia which contributes the superior articular surface of the ankle joint at the tibiotalar articulation as well as the medial malleolus. Another key bony landmark is the tibial tuberosity which sits several centimeters below the joint line and the inferior patellar pole and serves as the attachment site for the patellar tendon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A strong fibrous structure, the interosseous membrane connects the tibia and fibula along the length of the two bones. Proximally, this structure, reinforced by strong anterior and posterior ligaments, forms a synovial joint, the proximal tibiofibular articulation. Distally, the interosseous membrane and three ligaments, the anterior, posterior, and transverse tibiofibular ligaments stabilize the superior ankle joint.",
"   </p>",
"   <p>",
"    Another fibrous structure, the crural fascia surrounds the bones and muscles of the lower leg. Fascial extensions and the interosseous membrane separate the muscles, nerves, and vessels of the lower leg into four distinct compartments (",
"    <a class=\"graphic graphic_figure graphicRef66579 \" href=\"mobipreview.htm?4/40/4740\">",
"     figure 1",
"    </a>",
"    ). Three of these, the anterior, posterior, and deep posterior compartments all border the tibia and can be compromised by tibial injury.",
"   </p>",
"   <p>",
"    Nerves and vessels lie within the anterior and the deep posterior compartments, and trauma that causes significant swelling in these compartments can result in neurovascular compromise. The key blood supply of the tibia arises from periosteal vessels and the nutrient artery. The nutrient artery originates from the posterior tibial artery and enters the posterolateral cortex at the middle third of the tibial shaft near the origin of the soleus muscle. Fractures in this region potentially compromise this blood supply.",
"   </p>",
"   <p>",
"    The periosteal vessels provide a less vulnerable circulation as they derive an abundant blood supply from the anterior tibial artery, which travels down along the interosseous membrane. Vascular compromise can arise proximally, from marked effusion of the knee joint or trauma that affects the popliteal artery before it branches into the anterior and posterior tibial arteries or at the level of the anterior tibial artery as it branches off the popliteal artery and passes through a gap in the interosseous membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The tibial nerve and several branches provide the key innervation to the muscles of the lower leg and foot. Nerve roots arise from L4 through S3. The posterior tibial nerve parallels the course of the posterior tibial artery and courses through the deep posterior compartment. In the popliteal space, branches of the tibial nerve provide innervation to the posterior compartment and to the popliteus muscle. The deep peroneal nerve branches and follows the course of the anterior tibial artery providing innervation to muscles in the anterior lower leg.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three types of forces lead to most tibial shaft fractures: low-energy, high-energy, and rotational. Low-energy forces, such as those involved in sporting injuries or falls from standing, generally lead to fracture in the distal tibial shaft. Fractures of the thicker proximal shaft typically arise from high-energy impact, as occurs with motor vehicle collisions. Tibial fractures from high-energy trauma are associated with higher complication rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/7\">",
"     7",
"    </a>",
"    ]. Rotational forces lead to oblique, spiral, or distal fractures.",
"   </p>",
"   <p>",
"    Direct trauma leads to transverse and comminuted fractures with the extent of comminution roughly proportional to the magnitude of force. Fractures from direct blows typically affect the anterior medial tibia, in part because of the lack of soft tissue protection.",
"   </p>",
"   <p>",
"    Classifications of tibial fractures based upon specific aspects of the bone injury or by the degree of associated soft tissue injury are used to guide orthopedic decision-making and help predict outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/1\">",
"     1",
"    </a>",
"    ]. The classification schemes for tibial shaft fractures used by orthopedists are beyond the scope of this discussion but were discussed in a 2003 review of treatment of closed tibial fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/1\">",
"     1",
"    </a>",
"    ], to which the interested reader is referred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SYMPTOMS AND EXAMINATION FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tibial shaft fractures result in localized swelling, pain, and the inability to bear weight. Significantly displaced fractures can lead to a shift in the alignment of the lower leg. Open fractures are common and overlying skin should be carefully examined for small lacerations.",
"   </p>",
"   <p>",
"    Severe fractures from high velocity trauma can be associated with neurovascular injury. Therefore, it is important to examine distal pulses and lower extremity motor and sensory function.",
"   </p>",
"   <p>",
"    Displaced tibial shaft fractures and those with considerable soft tissue trauma are at increased risk for developing acute compartment syndrome (ACS), a limb-threatening complication. Symptoms and signs of ACS can include increasing and unrelenting pain, tense swelling, and pain with passive flexion and extension of the toes. ACS is discussed in detail separately. Definitive diagnosis involves measuring compartment pressures directly. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/57/8090?source=see_link\">",
"     \"Acute compartment syndrome of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain film radiographs to assess tibial shaft fracture include anteroposterior (AP) and lateral views. These should incorporate the entire length of the lower leg from knee to ankle. Radiolucent splinting prevents additional injury and allows proper positioning to best visualize fractures.",
"   </p>",
"   <p>",
"    As noted above, the orthopedic literature describes numerous fracture classification systems and radiographic grading criteria that are beyond the scope of this discussion. However, radiographic findings that are important for initial evaluation include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anatomical location of the fracture",
"     </li>",
"     <li>",
"      Determination of separation or overlap of fracture fragments in order to distinguish displaced from nondisplaced fractures",
"     </li>",
"     <li>",
"      Fracture pattern (eg, transverse, oblique, comminuted)",
"     </li>",
"     <li>",
"      Degree of angulation",
"     </li>",
"     <li>",
"      Presence of malrotation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These radiographic features help to determine whether conservative or operative treatment is preferred (",
"    <a class=\"graphic graphic_figure graphicRef85950 \" href=\"mobipreview.htm?19/3/19510\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef85951 \" href=\"mobipreview.htm?2/10/2213\">",
"     image 1",
"    </a>",
"    ). Significant malrotation, malalignment (angulation), and displacement for tibial shaft fractures are defined as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Malrotated fractures have &ge;10 degrees of rotation in any plane",
"     </li>",
"     <li>",
"      Malaligned fractures are angulated &ge;10 degrees",
"     </li>",
"     <li>",
"      Displaced fractures have &ge;5 mm of displacement",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ORTHOPEDIC REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many physicians refer traumatic tibial fractures to orthopedists for definitive care. Rare exceptions to this would be minor, non-displaced fractures. Physicians managing such fractures must be proficient in the application and management of long-leg casts.",
"   </p>",
"   <p>",
"    Emergent surgical referral is required for open (compound) fractures, fractures with evidence of neurovascular injury or compartment syndrome, and fractures associated with dislocation of the knee or ankle (which must be reduced immediately). Time to operative intervention correlates with the risk of infection in open tibial fractures: a delay greater than six hours greatly increases the risk of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/8\">",
"     8",
"    </a>",
"    ]. Urgent referral, within a day or two of injury, is needed for severely comminuted fractures and markedly displaced fractures (assuming there is no neurovascular compromise).",
"   </p>",
"   <p>",
"    Orthopedists do not agree on how much displacement is acceptable or when to proceed with intramedullary nailing. Early assessment by the orthopedist helps to determine the treatment strategy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial treatment is focused on symptomatic relief and preventing further injury. Stabilization of the fracture is accomplished with a long leg posterior splint. Ice, elevation, and light compression minimize swelling and, along with analgesics, help to control pain. These treatments continue for 48 to 72 hours, or until definitive management begins. Close monitoring during the initial treatment phase must allow clinicians or caretakers to detect any emerging compartment syndrome or change in neurovascular status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DEFINITIVE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closed, well-aligned, nondisplaced tibial shaft fractures may be definitively treated with a long leg cast. Optimal management of displaced tibial shaft fractures has not been definitively determined, but intramedullary nailing is common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Long leg casting",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to effectively protect the tibia following fracture, a long-leg cast incorporates the knee and ankle joint preventing excess motion above and below the fracture. The cast extends from the metatarsal heads to the upper thigh. The ankle is positioned in neutral with no dorsal or plantar flexion. Knee position allows up to 5 degrees of flexion. This type of cast permits limited weight bearing to begin when clinically feasible. Plaster casts mold more closely to the leg and are preferred for the first few weeks of treatment. At the first cast change a switch to fiberglass material allows the patient a much lighter cast and easier ambulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Operative interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;If long leg casting fails to achieve or maintain adequate reduction of tibial shaft fractures, the patient needs operative intervention.",
"   </p>",
"   <p>",
"    It remains uncertain whether operative interventions, such as intramedullary nailing (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50245 \" href=\"mobipreview.htm?20/16/20750\">",
"     image 2",
"    </a>",
"    ) or external fixation, result in better outcomes than closed management with casting. A meta-analysis of studies that compared cast treatment to open reduction and internal fixation or intramedullary nailing found insufficient evidence to support the superiority of any approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/11\">",
"     11",
"    </a>",
"    ]. Another review that pooled data from prospective studies of cast versus operative treatment in 895 fractures was also inconclusive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An observational study, performed in a developing country, of 68 patients with tibial fractures treated alternately with cast bracing or intramedullary nailing reported no major differences in functional outcomes but lower treatment costs in the cast bracing group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/13\">",
"     13",
"    </a>",
"    ]. Thus, cast bracing may offer advantages in areas with limited resources and less access to surgical services.",
"   </p>",
"   <p>",
"    The following observations may be pertinent to decision making regarding management in an individual patient:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Operative treatment leads to lower rates of non-union or malunion.",
"     </li>",
"     <li>",
"      Cast treatment entails a lower risk of superficial infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, if long leg casting fails to achieve or maintain adequate reduction of tibial shaft fractures, the patient needs operative intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loosening of the cast typically occurs as swelling decreases. Thus, the cast is likely to need changing every two to three weeks. Plaster casts mold more closely to the leg and are preferred for the first two to three weeks of treatment. Subsequently, a switch to lighter fiberglass material allows for easier ambulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/1,8\">",
"     1,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The patient should remain non-weight bearing for the first one to two weeks in the long leg cast; progress to partial and then full weight bearing. Serial radiographs are obtained at weekly follow-up visits to identify any loss of reduction or change in position. After approximately four weeks, visits are extended to every two weeks and these continue until evidence of satisfactory bone healing occurs, ie, callus formation and filling in of the fracture line.",
"   </p>",
"   <p>",
"    Most nondisplaced tibial shaft fractures heal within 10 to 14 weeks. Definitive treatment entails four to six weeks of immobilization in a long leg cast. The cast is exchanged for a short leg walking brace (",
"    <a class=\"graphic graphic_picture graphicRef86895 \" href=\"mobipreview.htm?38/45/39633\">",
"     picture 3",
"    </a>",
"    ) when satisfactory bone healing is documented. Newer, lightweight walking appliances with air or other cushioned padding allow more aggressive rehabilitation once the patient progresses enough to use them.",
"   </p>",
"   <p>",
"    Although prolonged absences from sedentary work are unnecessary, many patients with tibial shaft fractures experience persistent pain and have difficulty returning to full activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/15\">",
"     15",
"    </a>",
"    ]. Clinicians should caution patients that healing takes time and that some symptoms may persist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2147279\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the days following injury, patients with tibial shaft fractures are at relatively high risk of developing acute compartment syndrome (ACS), a limb-threatening complication. Patients must be monitored closely for signs of ACS during this period. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/57/8090?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute compartment syndrome of the extremities\", section on 'Clinical features and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other potential short-term complications include infection, which occurs more frequently with open fractures and those requiring surgical fixation, and loss of alignment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/14\">",
"     14",
"    </a>",
"    ]. Possible longer term complications include malunion and nonunion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/42/6823?source=see_link\">",
"     \"General principles of fracture management: Early and late complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Observational studies suggest that patients treated with intramedullary nailing regain function but often experience chronic sequelae, including knee pain, leg swelling, reduced ankle mobility, thigh and calf muscle atrophy, and osteoarthritis of the knee or ankle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/16\">",
"     16",
"    </a>",
"    ]. Injury to the peroneal nerve occurs more often with fractures managed surgically, but the resulting deficit is usually sensory and temporary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/7\">",
"     7",
"    </a>",
"    ]. Athletes recovering from tibial shaft fractures should be aware that calf atrophy can persist for years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cigarette smoking increases the risk of nonunion and malunion with all fracture types, but multiple observational studies report an association between smoking and impaired healing of tibial fractures in particular [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/18-22\">",
"     18-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     RETURN TO SPORT OR WORK",
"    </span>",
"    &nbsp;&mdash;&nbsp;If patients' occupations require minimal walking or standing, they can often return to work once they progress out of a long leg cast. For athletes, cross training in non-weight bearing activities begins at approximately four to six weeks following the injury.",
"   </p>",
"   <p>",
"    Retrospective studies have examined the recovery time for tibial shaft fractures in soccer athletes. The following observations are illustrative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 50 consecutive adult soccer athletes with tibial shaft fractures, all reported good or excellent outcomes with treatment but only 54 percent returned to competitive soccer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A retrospective review of 31 athletes with lower leg fractures found a significant delay in return to sport. For tibial fractures the return time averaged 35 weeks but if both tibia and fibula were fractured the athletes needed 40 weeks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even though athletes rate outcomes highly, the severity of a tibial fracture indicates that they face a protracted recovery time before highly competitive activities can resume.",
"   </p>",
"   <p>",
"    Prevention of tibial fractures in athletes is a worthy goal. However, a simple measure, shin guards, shows little effect on these injuries as 90 percent of soccer players experienced the injury while wearing them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30790/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/33/12819?source=see_link\">",
"       \"Patient information: Shinbone fracture (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Midshaft fractures typically occur as a result of high-energy injuries as in a motor vehicle crash or pedestrian vehicle collision. Low-energy injuries more often lead to distal tibial fractures, while rotational injuries (foot planted and leg twists) cause spiral, oblique, or distal fractures. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most physicians refer traumatic tibial shaft fractures to an orthopedist for definitive management. Fractures with comminution, significant angulation, or significant displacement must be referred. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Indications for orthopedic referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Emergent surgical referral is required for all open fractures, fractures associated with neurovascular injury or suspected acute compartment syndrome, and fractures associated with dislocation of the knee or ankle. Tibial shaft fractures carry a relatively high risk for acute compartment syndrome, a potentially limb-threatening complication. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/57/8090?source=see_link\">",
"       \"Acute compartment syndrome of the extremities\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Initial management includes use of a posterior long leg splint, analgesia, light compression, analgesics and non-weight bearing status with crutches. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Initial treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Minor, nondisplaced, well-aligned, tibial shaft fractures may be managed conservatively by physicians who are skilled at the application of a long leg cast and with monitoring for complications, such as neurovascular injury and compartment syndrome. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Definitive treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial splint is exchanged for a long leg cast after 48 to 72 hours. A plaster cast is preferred at the initial exchange.",
"     </li>",
"     <li>",
"      The plaster cast may be exchanged for a lighter weight fiberglass cast after two to three weeks.",
"     </li>",
"     <li>",
"      If radiographic healing is progressing normally six weeks following the initial injury, the long leg cast is exchanged for a short leg walking cast, or a commercial cushioned lower leg walking splint. Cigarette smoking increases the risk of nonunion, malunion, and delayed fracture healing. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Follow-up care'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2147279\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/1\">",
"      Schmidt AH, Finkemeier CG, Tornetta P 3rd. Treatment of closed tibial fractures. Instr Course Lect 2003; 52:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/2\">",
"      Chang WR, Kapasi Z, Daisley S, Leach WJ. Tibial shaft fractures in football players. J Orthop Surg Res 2007; 2:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/3\">",
"      Court-Brown CM, McBirnie J. The epidemiology of tibial fractures. J Bone Joint Surg Br 1995; 77:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/4\">",
"      Boden BP, Lohnes JH, Nunley JA, Garrett WE Jr. Tibia and fibula fractures in soccer players. Knee Surg Sports Traumatol Arthrosc 1999; 7:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/5\">",
"      Gr&uuml;tter R, Cordey J, B&uuml;hler M, et al. The epidemiology of diaphyseal fractures of the tibia. Injury 2000; 31 Suppl 3:C64.",
"     </a>",
"    </li>",
"    <li>",
"     Duke Orthopaedics. Wheeless' Textbook of Orthopedics. www.wheelessonline.com (Accessed March 7, 2005).",
"    </li>",
"    <li>",
"     Petrisor, BA, Bhandari, M, Schemitsch, E. Tibia and Fibula Fractures. In: Rockwood and Green's Fractures in Adults, 2, Bucholz, RW, Court-Brown, CM, Heckman, JD, Tornetta, Paul III (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. p.1867.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/8\">",
"      Khatod M, Botte MJ, Hoyt DB, et al. Outcomes in open tibia fractures: relationship between delay in treatment and infection. J Trauma 2003; 55:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/9\">",
"      Busse JW, Morton E, Lacchetti C, et al. Current management of tibial shaft fractures: a survey of 450 Canadian orthopedic trauma surgeons. Acta Orthop 2008; 79:689.",
"     </a>",
"    </li>",
"    <li>",
"     Patellar, Tibial and Fibular Fractures. In: Fracture Management for Primary Care, Eiff, MP, Hatch, RL, Calmbach, WL (Eds), Saunders, Philadelphia 2003. p.263.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/11\">",
"      Littenberg B, Weinstein LP, McCarren M, et al. Closed fractures of the tibial shaft. A meta-analysis of three methods of treatment. J Bone Joint Surg Am 1998; 80:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/12\">",
"      Coles CP, Gross M. Closed tibial shaft fractures: management and treatment complications. A review of the prospective literature. Can J Surg 2000; 43:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/13\">",
"      Batta V, Dwyer AJ, Gulati A, et al. No difference in the long term final functional outcome after nailing or cast bracing of high energy displaced tibial shaft fractures. J Trauma Manag Outcomes 2012; 6:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/14\">",
"      Cannada LK, Anglen JO, Archdeacon MT, et al. Avoiding complications in the care of fractures of the tibia. J Bone Joint Surg Am 2008; 90:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/15\">",
"      Ferguson M, Brand C, Lowe A, et al. Outcomes of isolated tibial shaft fractures treated at level 1 trauma centres. Injury 2008; 39:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/16\">",
"      Lefaivre KA, Guy P, Chan H, Blachut PA. Long-term follow-up of tibial shaft fractures treated with intramedullary nailing. J Orthop Trauma 2008; 22:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/17\">",
"      Khalid M, Brannigan A, Burke T. Calf muscle wasting after tibial shaft fracture. Br J Sports Med 2006; 40:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/18\">",
"      Moghaddam A, Zimmermann G, Hammer K, et al. Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury 2011; 42:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/19\">",
"      Adams CI, Keating JF, Court-Brown CM. Cigarette smoking and open tibial fractures. Injury 2001; 32:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/20\">",
"      Castillo RC, Bosse MJ, MacKenzie EJ, et al. Impact of smoking on fracture healing and risk of complications in limb-threatening open tibia fractures. J Orthop Trauma 2005; 19:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/21\">",
"      Harvey EJ, Agel J, Selznick HS, et al. Deleterious effect of smoking on healing of open tibia-shaft fractures. Am J Orthop (Belle Mead NJ) 2002; 31:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/22\">",
"      Hoogendoorn JM, van der Werken C. [The adverse effects of smoking on healing of open tibial fractures]. Ned Tijdschr Geneeskd 2002; 146:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30790/abstract/23\">",
"      Lenehan B, Fleming P, Walsh S, Kaar K. Tibial shaft fractures in amateur footballers. Br J Sports Med 2003; 37:176.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 215 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30790=[""].join("\n");
var outline_f30_4_30790=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PERTINENT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SYMPTOMS AND EXAMINATION FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INDICATIONS FOR ORTHOPEDIC REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DEFINITIVE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Long leg casting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Operative interventions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2147279\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      RETURN TO SPORT OR WORK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/215\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/215|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?2/10/2213\" title=\"diagnostic image 1\">",
"      Displaced tibial shaft fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/16/20750\" title=\"diagnostic image 2\">",
"      Tibial and fibular fracture ORIF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/215|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/40/4740\" title=\"figure 1\">",
"      Cross section lower leg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/3/19510\" title=\"figure 2\">",
"      Nondisplaced tibial shaft fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/215|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/14/42213\" title=\"picture 1\">",
"      Anterior anatomy of tibia and fibula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/45/27349\" title=\"picture 2\">",
"      Lateral anatomy of tibia and fibula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/45/39633\" title=\"picture 3\">",
"      Walking boot or brace",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/57/8090?source=related_link\">",
"      Acute compartment syndrome of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/42/6823?source=related_link\">",
"      General principles of fracture management: Early and late complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26358?source=related_link\">",
"      Overview of tibial fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/33/12819?source=related_link\">",
"      Patient information: Shinbone fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/46/24296?source=related_link\">",
"      Tibial and fibular shaft fractures in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_4_30791="Darier histo";
var content_f30_4_30791=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Histopathology of Darier's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic examination of lesional skin in Darier disease shows a suprabasal cleft containing acantholytic cells, eosinophilic dyskeratotic cells (corps ronds) in the epidermis and flattened parakeratotic cells (grains) in the stratum corneum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30791=[""].join("\n");
var outline_f30_4_30791=null;
var title_f30_4_30792="RA PIP erosions";
var content_f30_4_30792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F85824%7ERADIOL%2F85836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F85824%7ERADIOL%2F85836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Plain radiograph of rheumatoid arthritis proximal interphalangeal joint erosions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plain x-ray of the right hand magnified at the proximal interphalangeal joints shows soft tissue swelling (yellow arrows) and mild erosive changes (white arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Waite, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Plain radiograph of a normal right hand (AP, lateral, and oblique)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 584px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The radiograph of the right hand in the AP (A), lateral (B), and oblique (C) projections are normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30792=[""].join("\n");
var outline_f30_4_30792=null;
var title_f30_4_30793="Early DAD micrograph";
var content_f30_4_30793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Early diffuse alveolar damage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 302px; height: 198px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph shows early diffuse alveolar damage with minimal alveolar septal thickening, hyperplasia of pneumocytes, and eosinophilic hyaline membranes (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey L Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal lung",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power photomicrograph shows alveoli containing capillaries within a narrow interstitium. The alveoli are lined with thin, elongated type I pneumoctes (red arrow) and smaller numbers of cuboidal type II pneumocytes (green arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven E Weinberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30793=[""].join("\n");
var outline_f30_4_30793=null;
var title_f30_4_30794="Management of chronic rhinosinusitis";
var content_f30_4_30794=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of chronic rhinosinusitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Daniel L Hamilos, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Jonathan Corren, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/4/30794/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/4/30794/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic rhinosinusitis (CRS) is defined as an inflammatory condition involving the paranasal sinuses and linings of the nasal passages, which persists for 12 weeks or longer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are four cardinal",
"    <span class=\"nowrap\">",
"     signs/symptoms",
"    </span>",
"    of CRS:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anterior",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      posterior mucopurulent drainage",
"     </li>",
"     <li>",
"      Nasal obstruction",
"     </li>",
"     <li>",
"      Facial pain, pressure,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fullness",
"     </li>",
"     <li>",
"      Decreased sense of smell",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At least TWO of these",
"    <span class=\"nowrap\">",
"     signs/symptoms",
"    </span>",
"    must be present to consider the diagnosis of CRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1-4,6\">",
"     1-4,6",
"    </a>",
"    ]. In addition, objective documentation of mucosal inflammation is required.",
"   </p>",
"   <p>",
"    The management of patients with each subtype of CRS will be discussed here. The microbiology and antimicrobial therapy of this disorder and the clinical manifestations and diagnosis of the different types of CRS are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link\">",
"     \"Microbiology and antibiotic management of chronic rhinosinusitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GOALS OF THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CRS cannot be \"cured\" in most patients, and therapy is intended to reduce symptoms and improve quality of life. Thus, the goals of CRS therapy include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Control of mucosal inflammation and edema",
"     </li>",
"     <li>",
"      Maintenance of adequate sinus ventilation and drainage",
"     </li>",
"     <li>",
"      Treatment of colonizing or infecting microorganisms, if present",
"     </li>",
"     <li>",
"      Reduction in the number of acute exacerbations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with CRS and asthma, medical management of CRS can lead to improvements in asthma control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mucosal remodeling, similar to that believed to occur in severe asthma, has been increasingly studied as a cause of irreversible chronic sinus disease. It is not clear to what extent treatment can slow or prevent this process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H97421985\">",
"    <span class=\"h1\">",
"     REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management of a patient with CRS is often supervised by a generalist. However, treatment of refractory CRS, and management of allergic fungal rhinosinusitis usually requires the input of a specialist.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Otolaryngology experts can obtain culture material directly from the sinuses, visualize mucosal abnormalities without imaging studies, and perform surgical procedures. They can also diagnose and manage associated otologic problems. Patients with stable CRS who develop changes to suggest a complication of CRS, such as orbital cellulitis, cavernous vein thrombosis, or erosion into the central nervous system, should be urgently evaluated by an otolaryngologist [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Allergy/immunology",
"      </span>",
"      specialists can diagnose and treat associated allergy, immunodeficiency, and asthma, and perform",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      desensitizations in patients with aspirin intolerance and nasal polyps.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVERVIEW OF MEDICAL THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple therapies are utilized in the management of CRS, including saline washes and sprays, topical and systemic glucocorticoids, antibiotics, antileukotriene agents, and antifungals. Treatment depends upon the types of CRS that are present.",
"   </p>",
"   <p>",
"    Most therapies for CRS have not been validated in randomized trials, although a consensus group has identified areas in which trials are needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/10\">",
"     10",
"    </a>",
"    ]. An overview of each therapy is provided in this section. The next section describes the specific ways in which these therapies are combined to manage different types of CRS. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Therapy for specific types of CRS'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nasal saline",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal irrigation with saline solutions and saline nasal sprays are helpful in all types of CRS. Washing the nasal cavities with saline reduces postnasal drainage, removes secretions, and rinses away allergens and irritants. Saline washes can be used immediately prior to administration of other intranasal medications, so that the mucosa is freshly cleansed when the medications are introduced.",
"   </p>",
"   <p>",
"    A variety of over-the-counter devices, including squeeze bottles, syringes, and pots are available. Patients can make their own saline solutions (",
"    <a class=\"graphic graphic_table graphicRef71059 \" href=\"mobipreview.htm?42/33/43548\">",
"     table 1",
"    </a>",
"    ) or buy commercially-prepared products. Nasal lavage (with at least 200 mL warmed saline per side) can be performed as needed only, daily, or multiple times daily, depending on the severity of symptoms. Systematic reviews of studies employing various forms of saline sprays and irrigation (performed one to four times daily) found that nasal saline is an effective adjunctive treatment for CRS, although less effective as monotherapy than topical glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We encourage patients with CRS to perform nasal irrigation in preference to using saline nasal sprays, based on our clinical impression and limited data that irrigation is the more effective technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H97421700\">",
"    <span class=\"h3\">",
"     Surfactants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of surfactants, such as baby shampoo, to saline has been proposed to prevent the formation of bacterial biofilm in CRS and to increase mucociliary clearance rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. An uncontrolled study examined the effects of a 1 percent solution of baby shampoo in physiologic saline, which was used to irrigate the sinuses twice daily for four weeks in 18 postsurgical patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/15\">",
"     15",
"    </a>",
"    ]. Sixty percent of patients reported subjective thinning of mucus and less postnasal drainage; however, no objective measures of mucosal disease or biofilm were measured. Based upon these preliminary findings, surfactants warrant further study in the management of CRS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Intranasal glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical glucocorticoids have been shown in randomized trials and a systematic review to be helpful in all types of CRS and are the cornerstone of maintenance treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1,17-22\">",
"     1,17-22",
"    </a>",
"    ]. These agents can be administered either as nasal sprays or as solutions for instillation. We typically begin therapy with nasal sprays. For patients with persistent nasal congestion or blockage despite consistent use of glucocorticoid nasal sprays, we suggest changing to nasal glucocorticoid instillation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Nasal sprays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical intranasal glucocorticoids (intranasal GCs) include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    propionate,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36080?source=see_link\">",
"     mometasone",
"    </a>",
"    furoate,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/45/33488?source=see_link\">",
"     ciclesonide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    dipropionate, and fluticasone furoate (",
"    <a class=\"graphic graphic_table graphicRef55833 \" href=\"mobipreview.htm?16/18/16685\">",
"     table 2",
"    </a>",
"    ). The efficacy of intranasal GC sprays in CRS is supported by randomized trials, and is reviewed in more detail subsequently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/18,21\">",
"     18,21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Maintenance treatment'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H23\">",
"     'Topical glucocorticoids'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    To optimize effectiveness and patient compliance with nasal sprays, we suggest the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preparations with once-daily dosing are convenient and can help optimize compliance. These include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      acetonide,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      propionate,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36080?source=see_link\">",
"       mometasone",
"      </a>",
"      furoate, or fluticasone furoate. Most intranasal glucocorticoids are used at a dose of one to two sprays in each nostril once or twice a day.",
"     </li>",
"     <li>",
"      If obvious mucus or crusting is present, patients can clean the nose with saline nasal sprays or irrigation before the nasal glucocorticoid is applied.",
"     </li>",
"     <li>",
"      Patients should be instructed to keep their head pointed slightly downward during spraying and avoid tilting the head back, as this can cause drainage of the medicine from the nose to the throat. In addition, they should avoid pointing the tip of the bottle at the septum to minimize septum irritation and bleeding.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Nasal glucocorticoid instillations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Instillation of glucocorticoid solutions into the nose provides superior topical application because these solutions can reach the middle meatus, where polyps often form, whereas nasal sprays generally cannot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/23\">",
"     23",
"    </a>",
"    ]. In the United Kingdom and some areas of Europe, solutions of either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/5/44120?source=see_link\">",
"     betamethasone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    propionate are commercially available as nasal drops [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/24\">",
"     24",
"    </a>",
"    ]. In the United States, glucocorticoid solutions prepared for nebulization, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    (Pulmicort Respules), can be used in this manner.",
"   </p>",
"   <p>",
"    Typically a 0.5 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    Respule is mixed with one teaspoon of saline, and this mixture is instilled in the right nostril once daily, after which the patient assumes a series of positions: first the head down forward position, then right lateral supine position, and finally in the supine position, each for one to two minutes (",
"    <a class=\"graphic graphic_figure graphicRef78384 \" href=\"mobipreview.htm?36/41/37526\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/25\">",
"     25",
"    </a>",
"    ]. The supine position must be used with caution, because in some patients, it will cause fluid to enter the eustachian tubes. Following this, the remaining nasal solution is expelled from the nose. The procedure is then repeated in the left nostril.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Efficacy &mdash; The efficacy of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      propionate nasal drops (FPNDs) was demonstrated in 54 patients with severe CRS with and without nasal polyposis, who had refractory disease despite treatment with intranasal glucocorticoid sprays and were awaiting functional endoscopic sinus surgery (FESS) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/24\">",
"       24",
"      </a>",
"      ]. Subjects received therapy with either FPNDs (400 micrograms per 0.4 mL, divided between the nostrils, once daily) or placebo for three months. There were six and one drop outs from the placebo and drug groups, respectively, largely due to uncontrolled symptoms. Three patients in the FPND group experienced nose bleeds. Subjects treated with FPNDs experienced significantly more improvement in symptoms, polyp volume, and nasal airflow. FESS was no longer required in 13 of 27 patients treated with FPNDs, compared to 6 of 27 in the placebo group.",
"      <br/>",
"      <br/>",
"      The efficacy of the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      solution available in the United States has not been evaluated in controlled trials, although we have found it to be very helpful for patients who are unable to control CRS symptoms with standard glucocorticoid nasal sprays.",
"     </li>",
"     <li>",
"      Safety &mdash; The long-term safety of glucocorticoid nasal instillations has not been established, although it has been demonstrated that very little of the instilled solution is retained [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/26\">",
"       26",
"      </a>",
"      ]. One study of 60 patients treated with &ldquo;dilute&rdquo;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      irrigation (0.50 mg diluted in 120 mL saline per nostril twice daily for one year) found no clinically significant changes in intraocular pressure or unstimulated plasma ACTH levels over the study duration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/27\">",
"       27",
"      </a>",
"      ]. However, this study was unable to demonstrate any clinical benefit from the &ldquo;dilute&rdquo; budesonide solution relative to saline solution alone. A smaller study involving nine patients treated with a &ldquo;concentrated&rdquo; budesonide solution (0.25 mg per nostril diluted in 5 mL saline once per nostril daily for 30 days administered with head tilting maneuvers) demonstrated a clinically significant improvement in sinonasal outcome measures and found no significant change in adrenal response to cosyntropin stimulation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/28\">",
"       28",
"      </a>",
"      ]. Despite the safety of &ldquo;concentrated&rdquo; budesonide solution demonstrated in the latter study, it is recommended to periodically evaluate the patient for possible systemic effects of the budesonide, including an increase in intraocular pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Oral glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral glucocorticoids, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , may be administered to patients with CRS for the following purposes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Relieving severe and refractory mucosal edema in CRS without nasal polyposis",
"     </li>",
"     <li>",
"      Reducing the size of polyps in CRS with nasal polyposis",
"     </li>",
"     <li>",
"      Minimizing mucosal inflammation in allergic fungal rhinosinusitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Doses for specific situations are discussed below. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Therapy for specific types of CRS'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Antimicrobials",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recognition that the pathophysiology of CRS involves complex inflammatory changes, rather than simply persistent bacterial infection, has lead to the reexamination of the role of antimicrobials in CRS. Evidence for the efficacy of antimicrobials as monotherapy is limited. The goal of managing CRS has now shifted to controlling the inflammation that predisposes patients to obstruction, thus minimizing the incidence of infections.",
"   </p>",
"   <p>",
"    Despite this, all forms of CRS are associated with poor sinus drainage and secondary bacterial infections from time to time. Most patients require systemic antibiotics to clear infections at the outset of therapy, and intermittently thereafter to treat acute exacerbations of CRS. The role of systemic antimicrobial agents beyond these two indications remains an area of investigation.",
"   </p>",
"   <p>",
"    The use of both systemic and topical antimicrobials in CRS, including choice of agent and dose, is discussed in detail separately. (See",
"    <a class=\"local\" href=\"#H34\">",
"     'Treating exacerbations of CRS'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link&amp;anchor=H14#H14\">",
"     \"Microbiology and antibiotic management of chronic rhinosinusitis\", section on 'Antimicrobial therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40395549\">",
"    <span class=\"h2\">",
"     Topical antimicrobials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical antibiotics can be administered with or without a nebulizer. Most studies have involved administration of nebulized antibiotic for three to six weeks in patients who have had prior sinus surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Delivery of topical antibiotics to the sphenoethmoidal region is challenging.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A systematic review concluded that there is low-level evidence for the use of antibiotic nasal irrigations or nebulizations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/31\">",
"       31",
"      </a>",
"      ]. The strongest evidence comes from studies of postsurgical patients and culture-directed therapy.",
"     </li>",
"     <li>",
"      In a subsequent double-blinded, placebo-controlled study of 22 patients with persistent sinonasal infection despite endoscopic sinus surgery, subjects were randomized to either a one-month, twice-daily treatment course of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33252?source=see_link\">",
"       mupirocin",
"      </a>",
"      sinonasal rinses or saline rinses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/32\">",
"       32",
"      </a>",
"      ]. The primary outcome was the presence or absence of a positive S. aureus culture at the end of treatment. In this study, 8 of 9 patients treated with mupirocin and 0 of 13 control-treated patients were culture-negative at the end of one month of treatment. However, when patients were prospectively reassessed at two to six months later, the effects of mupirocin treatment were no longer evident suggesting that the benefit was not sustained.",
"     </li>",
"     <li>",
"      Topical irrigation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/35/34352?source=see_link\">",
"       tobramycin",
"      </a>",
"      (80 to 100",
"      <span class=\"nowrap\">",
"       mg/L)",
"      </span>",
"      has also been used in a similar fashion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/33\">",
"       33",
"      </a>",
"      ]. Most studies reported a low rate of side effects. Twice-daily irrigation with gentamicin for 3 to 15 weeks caused low but measurable systemic absorption, with blood levels ranging from 0.3 to 0.7",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/34\">",
"       34",
"      </a>",
"      ]. However, sensorineural hearing loss was noted in 23 percent of patients with cystic fibrosis who had used frequent irrigations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/35\">",
"       35",
"      </a>",
"      ]. Therefore, topical aminoglycosides should be used with caution and for a defined treatment period. In addition, treatment of the sphenoethmoidal region with topical aminoglycosides is contraindicated because of potential ototoxicity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the author&rsquo;s experience, topical antibiotics are most useful in patients who have had prior surgery and who have documented infection with S. aureus, MRSA, or a gram-negative bacteria (eg, Pseudomonas aeruginosa, Klebsiella oxytoca, Stenotrophomonas maltophilia). Depending on the antimicrobial susceptibility of the infecting organism, treatment is given with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33252?source=see_link\">",
"     mupirocin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/35/34352?source=see_link\">",
"     tobramycin",
"    </a>",
"    once or twice daily for four weeks. It is important to repeat the nasal endoscopic examination following treatment to confirm whether the infection was eradicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Antileukotriene agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cysteinyl leukotrienes are inflammatory mediators that cause mucus secretion, increased vascular permeability, and mucosal edema in the upper and lower airways. Antileukotriene agents may be used as an adjunct therapy to topical glucocorticoids in patients with CRS, although this is presently an off-label use for these agents.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"     Montelukast",
"    </a>",
"    , which is approved for the treatment of allergic rhinitis, has been shown to be superior to placebo but inferior to topical glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link\">",
"     \"Pharmacotherapy of allergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/1/30746?source=see_link\">",
"     \"Agents affecting the 5-lipoxygenase pathway in the treatment of asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Leukotriene D4 (LTD4) receptor blockers include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"     montelukast",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/54/20325?source=see_link\">",
"     zafirlukast",
"    </a>",
"    . It is unclear whether the 5-lipoxygenase inhibitor",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/33/17940?source=see_link\">",
"     zileuton",
"    </a>",
"    is any more effective than LTD4 receptor blockers in the management of allergic rhinitis.",
"   </p>",
"   <p>",
"    Antileukotriene agents are also used in the management of CRS with nasal polyposis, although the evidence supporting their use comes mainly from small, uncontrolled studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'CRS with nasal polyposis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H97421799\">",
"    <span class=\"h2\">",
"     Unproven therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unproven therapies include oral or topical antifungal medications and probiotics.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Oral or topical antifungals",
"      </strong>",
"      : Fungal colonization has been implicated in the pathophysiology of CRS, most clearly in allergic fungal rhinosinusitis (AFRS). Accordingly, antifungal medications in both systemic and topical forms have been studied in clinical trials of CRS, with mostly unpromising results [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/38-43\">",
"       38-43",
"      </a>",
"      ]. A systematic review and a meta-analysis, which pooled studies of antifungal therapy for all types of CRS, found no statistically significant benefit of topical or systemic antifungals over placebo and higher rates of adverse events in the antifungal groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/44,45\">",
"       44,45",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Despite this, it has been the author's experience that topical antifungal treatment with either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/15/20730?source=see_link\">",
"       itraconazole",
"      </a>",
"      can be beneficial in a subset of patients with CRS without NP, and specifically in patients who have failed a trial of topical glucocorticoid irrigations and have persistent mucosal thickening and mucus production, with no evidence of bacterial infection.",
"     </li>",
"     <li>",
"      <strong>",
"       Probiotics",
"      </strong>",
"      : Oral probiotic therapy was evaluated in a randomized trial of 77 patients with different types of CRS, treated with either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      rhamnosus R0011 strain (500 million active cells per tablet) or placebo for four weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/43\">",
"       43",
"      </a>",
"      ]. There were no differences between the two groups in sinonasal quality of life scores.",
"     </li>",
"     <li>",
"      <strong>",
"       Complementary and alternative therapies",
"      </strong>",
"      : Many patients try alternative and complementary therapies, either instead of or in combination with conventional therapies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. Most of these therapies, including use of herbal tea, botanicals and other herbal medicines, vitamins, homeopathy, acupuncture, massage, reflexology, yoga, diet modifications, chiropractics, and acupuncture have not been studied in controlled clinical trials but rather discussed in open treatment trials [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/46-51\">",
"       46-51",
"      </a>",
"      ]. Given the limited reports and lack of rigorously controlled studies, it is not possible to ascribe better results to any one type of treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     THERAPY FOR SPECIFIC TYPES OF CRS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CRS can be divided into three subtypes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      CRS without nasal polyposis (CRS without NP)",
"     </li>",
"     <li>",
"      CRS with nasal polyposis (CRS with NP)",
"     </li>",
"     <li>",
"      Allergic fungal rhinosinusitis (AFRS)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are different strategies for managing each subtype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1198365\">",
"    <span class=\"h2\">",
"     Guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consensus groups in several countries have published guidelines for the management of CRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1-4,6\">",
"     1-4,6",
"    </a>",
"    ]. There are some significant differences among the recommendations in these publications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/52\">",
"     52",
"    </a>",
"    ]. The approach in this topic review is most similar to the American guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/2,4,6\">",
"     2,4,6",
"    </a>",
"    ]. Deviations based upon the author's practice or opinions are identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     CRS without nasal polyposis",
"    </span>",
"    &nbsp;&mdash;&nbsp;CRS without nasal polyposis (CRS without NP) is the most common form of CRS, accounting for approximately two-thirds of cases. Factors contributing to chronic sinus inflammation may include allergic and nonallergic rhinitis, structural abnormalities,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunodeficiency. Patients with this condition do not have nasal polyposis, by definition. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24297064\">",
"    <span class=\"h3\">",
"     Intensive medical management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intensive medical management, as described in this section, is appropriate for patients with symptoms and CT findings suggestive of CRS without nasal polyposis who have",
"    <strong>",
"     not",
"    </strong>",
"    received treatment in the immediate past. For such patients, two potential initial treatment options are presented below:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1813323\">",
"    <span class=\"h4\">",
"     Option 1: Intensive treatment including oral glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;One option for intensive medical management consists of a brief course of oral glucocorticoids, combined with a prolonged course of oral antibiotics and one or more adjunctive therapies. This is the approach preferred by the author.",
"   </p>",
"   <p>",
"    A typical regimen involves:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (in adults), 20 mg twice daily for five days, followed by 20 mg daily for five days (ie, total of 10 days of treatment)",
"      <br/>",
"      <br/>",
"      PLUS",
"     </li>",
"     <li>",
"      Three to four weeks of oral antibiotics: the currently recommended agents are reviewed separately. This may be extended for up to six weeks (or for seven days after symptoms have cleared), in patients with colored secretions that are improving gradually but have not cleared [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link&amp;anchor=H16#H16\">",
"       \"Microbiology and antibiotic management of chronic rhinosinusitis\", section on 'Empiric regimens'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to antibiotics and oral glucocorticoids, we administer one or more of the following adjunctive treatments, which are continued after the oral antibiotics and glucocorticoids are completed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intranasal saline irrigations or saline nasal spray [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Nasal saline'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Topical glucocorticoid spray or nasal instillations, which were shown to be beneficial in the treatment of CRS without NP in a systematic review [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/22\">",
"       22",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Intranasal glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The effectiveness of combined therapy with both systemic glucocorticoids and antibiotic therapy was demonstrated in a randomized trial of 48 children (ages 6 to 17 years) with CRS who had previously failed at least three 10- to 14-day courses of broad-spectrum antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/54\">",
"     54",
"    </a>",
"    ]. Subjects were treated with 30 days of",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"      amoxicillin",
"     </a>",
"     /clavulanate",
"    </span>",
"    (at weight-appropriate doses) combined with either placebo or a 15-day tapering course of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (beginning at 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily for the first 10 days). Adverse events were minimal in both groups. Children treated with",
"    <span class=\"nowrap\">",
"     glucocorticoids/antibiotics",
"    </span>",
"    had significantly greater reductions in total symptom scores and in CT scores compared to those given",
"    <span class=\"nowrap\">",
"     placebo/antibiotics.",
"    </span>",
"    Complete clinical recovery occurred in 17 and 7 patients in the combined treatment and antibiotic-only groups, respectively. Relapse rates over the ensuing six months were lower in the combined treatment group (43 versus 25 percent), although the difference was not significant.",
"   </p>",
"   <p>",
"    Additional support for this approach consists of retrospective series in both adults and children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whenever possible, the choice of antibiotic treatment should be guided by cultures of purulent mucus obtained from the middle meatus or another accessible sinus ostium. Cultures should be obtained endoscopically. Choice of antimicrobial agent is made empirically if this is not feasible. Nasal swabs are not helpful because they are not representative of sinus contents. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link&amp;anchor=H16#H16\">",
"     \"Microbiology and antibiotic management of chronic rhinosinusitis\", section on 'Empiric regimens'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link&amp;anchor=H35#H35\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\", section on 'Sinus cultures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Empiric antibiotic treatment is",
"    <strong>",
"     not",
"    </strong>",
"    recommended in the following clinical settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the patient has recently failed antibiotic treatment with a similar regimen",
"     </li>",
"     <li>",
"      If the patient has a history of infection with gram-negative or methicillin-resistant Staphylococcus or another highly drug-resistant bacteria",
"     </li>",
"     <li>",
"      If the patient is highly immunosuppressed and therefore at risk for invasive fungal rhinosinusitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20471416\">",
"    <span class=\"h4\">",
"     Option 2: Intensive treatment including long-term macrolides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another approach to intensive medical management is endorsed by European and British guidelines, although based on available data, the authors and editors believe that the role of macrolides in intensive medical management has not been adequately demonstrated. This approach consists of a prolonged course of macrolide antibiotics (which have both antiinflammatory and antimicrobial properties), combined with various topical therapies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1,17\">",
"     1,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One randomized trial of 90 patients compared intensive medical treatment that included macrolides to endoscopic surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/7\">",
"       7",
"      </a>",
"      ]. In this trial, participants were randomly assigned either to endoscopic surgery or to a medical regimen consisting of oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      for three months, alkaline (bicarbonate in saline) nasal irrigations, and a nasal spray containing glucocorticoids and a decongestant. Slightly more than one-half of patients had CRS without polyposis. Patients treated with surgery subsequently received two weeks of combination medical management (as above), and then",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      nasal spray thereafter. However, several methodological features of this study made it challenging to interpret. Medical therapy late in the study could be tailored to each patient&rsquo;s symptoms, making it difficult to identify a true control group and assess the value of any one therapy. In addition, no sham surgery was performed on the medically treated subjects, so a possible placebo effect in the surgical arm could not be excluded. Nevertheless, symptom scores and endoscopic findings at 6 and 12 months were not different in the two treatment arms, both of which improved significantly, and both approaches were well tolerated.",
"     </li>",
"     <li>",
"      In another randomized trial of 60 patients with CRS (52 percent with polyps), subjects were treated with low-dose oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      (500 mg daily for 3 days, then 500 mg per week for 11 weeks), or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/57\">",
"       57",
"      </a>",
"      ]. There were no significant differences in outcome between the two groups.",
"     </li>",
"     <li>",
"      A randomized, placebo-controlled study of 64 patients compared 12 weeks of therapy with 150 mg of roxithromycin daily or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/58\">",
"       58",
"      </a>",
"      ]. Patients in the roxithromycin group showed a statistically significant change from baseline in SNOT-20 score at 12 weeks, which was not seen in the placebo group. By using a &lsquo;&lsquo;change from baseline&rsquo;&rsquo; analysis, the roxithromycin group also showed an improvement in saccharine transit time and nasal endoscopy not seen in the placebo group. However, the statistical analysis in this study was unconventional in that it evaluated the results of each treatment arm at study end against respective values at baseline rather than a more conventional comparison of the change from baseline in each arm using an analysis of covariance model.",
"     </li>",
"     <li>",
"      Other studies exist, although they are limited by lack of sufficient controls or blinding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/58-61\">",
"       58-61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9622221\">",
"    <span class=\"h4\">",
"     Incomplete response",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients in whom intensive medical treatment appears to help but does not result in sufficient improvement in symptoms or resolution of CT findings, a second course of empiric intensive treatment can be undertaken provided the following conditions are true:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      There is no clear indication for surgical intervention (see",
"      <a class=\"local\" href=\"#H32\">",
"       'Indications for surgery'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      The patient does not have any signs or symptoms concerning for other conditions and does not appear toxic",
"     </li>",
"     <li>",
"      The patient prefers to continue medical treatment in order to avoid surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In our experience, the likelihood of success following a second course of empiric intensive treatment is lower than that with the initial course. The next logical step after failure of intensive medical treatment is sinus surgery. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Indications for surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Maintenance treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintenance treatment for CRS without nasal polyposis is guided by the patient's symptoms and by the presence or absence of underlying allergic rhinitis.",
"   </p>",
"   <p>",
"    We usually initiate a maintenance regimen of a glucocorticoid nasal spray and saline irrigation in all patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/17\">",
"     17",
"    </a>",
"    ]. The efficacy of glucocorticoid nasal sprays was evaluated in a trial of 167 patients with CRS and persistent symptoms despite two weeks of oral antibiotics, in which subjects were randomized to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    nasal spray (128 micrograms twice daily) or placebo for 20 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/21\">",
"     21",
"    </a>",
"    ]. The active therapy significantly reduced both morning -1.40 (95% CI, -2.18 to -0.62) and evening -1.37 (95% CI, -2.15 to -0.58) symptom scores from baseline, compared to placebo, with the greatest impact in patients with underlying allergic rhinosinusitis.",
"   </p>",
"   <p>",
"    For patients who have persistent symptoms despite consistent use of glucocorticoid nasal sprays, we advise them to change to nasal glucocorticoid instillations, as described previously. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Nasal glucocorticoid instillations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Treatment of underlying allergic rhinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with CRS and concomitant allergic rhinitis, other therapies, including remediation of allergen exposure, allergen immunotherapy, and oral and topical antihistamines may be helpful.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allergen remediation measures in the home or workplace, and specific allergen immunotherapy to reduce sensitivity to specific allergens can help reduce mucosal edema over time. These interventions are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/48/34569?source=see_link\">",
"       \"Allergen avoidance in the treatment of asthma and allergic rhinitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/8/39049?source=see_link\">",
"       \"Subcutaneous immunotherapy for allergic disease: Indications and efficacy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antihistamines may be helpful in patients with CRS and concomitant allergic rhinitis, although their relative contribution has not been studied [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/62\">",
"       62",
"      </a>",
"      ]. Antihistamines (oral and topical) are reviewed separately (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link&amp;anchor=H25107382#H25107382\">",
"       \"Pharmacotherapy of allergic rhinitis\", section on 'Oral antihistamines'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link&amp;anchor=H25107431#H25107431\">",
"       \"Pharmacotherapy of allergic rhinitis\", section on 'Antihistamine nasal sprays'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27882904\">",
"    <span class=\"h3\">",
"     Adjunctive therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antileukotriene agents may be useful in patients with refractory nasal congestion and postnasal drainage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/63\">",
"     63",
"    </a>",
"    ]. Chronic use of oral decongestants, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    , is generally avoided for maintenance treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     CRS with nasal polyposis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical patient with CRS with nasal polyposis is bothered mostly by nasal congestion, vague facial or sinus fullness, postnasal drainage,",
"    <span class=\"nowrap\">",
"     anosmia/hyposmia,",
"    </span>",
"    and lacks features of acute or chronic infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial treatment is intended to reduce the size and extent of nasal polyps and control mucosal inflammation. Assuming the patient does not have facial",
"    <span class=\"nowrap\">",
"     pain/pressure",
"    </span>",
"    or purulent drainage, bacterial infection is unlikely, and initial treatment focuses on establishing a regimen that reduces mucosal inflammation and shrinks nasal polyps.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Oral glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brief course of oral glucocorticoids may be administered if the patient has nasal blockage or impaired sense of smell. This is sometimes referred to as a &ldquo;medical polypectomy,&rdquo; and in most cases, results in significant reduction in polyp tissue and clinical improvement.",
"   </p>",
"   <p>",
"    A systematic review of randomized trials concluded that oral glucocorticoids were helpful for the short-term treatment of nasal polyposis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/64-67\">",
"     64-67",
"    </a>",
"    ]. In a subsequent trial, 60 adults with moderate to severe nasal polyposis were randomly assigned to oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    (25 mg daily) or placebo for two weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/68\">",
"     68",
"    </a>",
"    ]. One-half of the subjects in each group were",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    intolerant based on nasal lysine-aspirin challenge. Both groups then received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    nasal drops (400 mcg twice daily) for nine weeks, followed by fluticasone propionate nasal spray (200 mcg twice daily) for 18 weeks. Polyp size, olfaction, and several measures of glucocorticoid toxicity were measured after each phase of treatment. The group treated with oral glucocorticoids experienced a significant reduction in polyp size and improvement in olfaction after the oral tablet phase that was preserved through the nasal drops phase, but lost by the end of the nasal spray phase. Evidence of adrenal suppression had resolved by the end of the nasal drops phase. Similarly, other studies showed benefit with short-term oral glucocorticoids using different doses, also typically over a two week period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/18,65-67\">",
"     18,65-67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We typically administer oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (in adults), 20 mg twice daily for five days, followed by 10 mg twice daily for five days, then 10 mg once daily for five days (ie, total of 15 days of treatment).",
"     </li>",
"     <li>",
"      British guidelines suggests",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      (0.5 mg per kilogram each morning for 5 to 10 days), accompanied by instillations of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/5/44120?source=see_link\">",
"       betamethasone",
"      </a>",
"      nasal drops (not available in the United States) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The response to oral glucocorticoids varies among patients. In a study of approximately 250 patients with nasal polyps, a predominance of eosinophils (which is the most common finding) in the pretreatment polyp tissue predicted a better response to therapy, compared with a predominance of neutrophils or a mixed histology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144997\">",
"    <span class=\"h4\">",
"     Surgery for glucocorticoid failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus surgery should be considered if oral glucocorticoids do not reduce polyp tissue sufficiently and the patient has persistent blockage or anosmia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Topical glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstay of maintenance treatment is topical glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/52,70\">",
"     52,70",
"    </a>",
"    ]. Several different topical glucocorticoids have been shown either to reduce the size or prevent the regrowth of NP following surgical removal, including (in alphabetic order)",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    dipropionate,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/45/33488?source=see_link\">",
"     ciclesonide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/39/33392?source=see_link\">",
"     flunisolide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    furoate, fluticasone propionate,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36080?source=see_link\">",
"     mometasone",
"    </a>",
"    furoate, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide (",
"    <a class=\"graphic graphic_table graphicRef55833 \" href=\"mobipreview.htm?16/18/16685\">",
"     table 2",
"    </a>",
"    ). A systematic review and randomized trials have demonstrated that these agents are effective, delivered either by intranasal spray [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/18,22,71\">",
"     18,22,71",
"    </a>",
"    ] or intranasal instillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Topical glucocorticoids may also be helpful in preventing the regrowth of nasal polyps following sinus surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/71,72\">",
"     71,72",
"    </a>",
"    ], although not all studies have demonstrated efficacy and the effect may not be equal in all patient populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/27,73\">",
"     27,73",
"    </a>",
"    ]. Specifically, topical glucocorticoids did not prevent polyp regrowth in a randomized trial of 60 patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    exacerbated respiratory disease (AERD) who had undergone sinus surgery and polypectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/27\">",
"     27",
"    </a>",
"    ]. The protocol compared three treatments: saline irrigation (60",
"    <span class=\"nowrap\">",
"     mL/nostril",
"    </span>",
"    twice daily), saline irrigation followed by intranasal",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    (64",
"    <span class=\"nowrap\">",
"     mcg/nostril);",
"    </span>",
"    and saline irrigation with aqueous budesonide (250",
"    <span class=\"nowrap\">",
"     mcg/60",
"    </span>",
"    <span class=\"nowrap\">",
"     mL/nostril),",
"    </span>",
"    all administered twice daily. Treatment was continued for one year. The primary outcome variable was change in quality of life on the Sinonasal Outcome Test (SNOT-21) at six months and one year. Patients in each arm of the study experienced an improvement in QOL-SNOT-21, but the improvement was waning by one year. There were no statistically significant differences between groups. Thus, some patients, such as those with AERD, may require more intensive therapy to prevent polyp regrowth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucosal colonization with Staphylococcus aureus has been found in 64 percent of patients with CRS and nasal polyposis, compared with roughly 30 percent in healthy individuals or patients with CRS. In addition, IgE antibodies directed against Staphylococcal superantigens have been found in the tissues of a high percentage of colonized polyposis patients. Based on these observations, a randomized, double-blind, placebo-controlled trial was conducted to assess whether",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    could reduce nasal polyp size and provide antiinflammatory effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/67\">",
"     67",
"    </a>",
"    ]. Doxycycline (200 mg on the first day followed by 100 mg once daily for 20 days) caused a small but statistically significant reduction in polyp size beginning at week 2 and persisting for 12 weeks. A significant reduction in nasal secretion eosinophil cationic protein (ECP) was also found after 20 days of doxycycline treatment. However, doxycycline caused no statistically significant improvement in nasal peak inspiratory flow rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Antileukotrienes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antileukotriene agents may be used as an adjunct to topical glucocorticoids in the treatment of CRS with NP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. Small randomized trials demonstrated modest benefit after one to two months of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"     montelukast",
"    </a>",
"    , either as monotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/74\">",
"     74",
"    </a>",
"    ] or as adjunctive therapy to oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    nasal spray [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/76\">",
"     76",
"    </a>",
"    ]. We usually administer a three month trial of montelukast, and continue it indefinitely in patients who experience clinical benefit.",
"   </p>",
"   <p>",
"    Antileukotrienes may not benefit all patients with nasal polyps equally; they may be more effective in those with concomitant asthma and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    intolerance (ie, the syndrome of aspirin exacerbated respiratory disease or AERD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/77\">",
"     77",
"    </a>",
"    ]. It is unclear whether the 5-lipoxygenase inhibitor",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/33/17940?source=see_link\">",
"     zileuton",
"    </a>",
"    is any more effective than LTD4 receptor blockers (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"     montelukast",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/54/20325?source=see_link\">",
"     zafirlukast",
"    </a>",
"    ). We treat most patients with AERD with some form of long-term antileukotriene therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Aspirin desensitization and therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the combination of CRS with NP, asthma, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    intolerance (AERD) may be candidates for aspirin desensitization, followed by daily aspirin therapy. A beneficial effect of aspirin desensitization on nasal polyposis had been noted by several groups as far back as 1983 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/78-81\">",
"     78-81",
"    </a>",
"    ]. Aspirin desensitization requires close monitoring for bronchospasm and is usually conducted by a specialist in drug desensitizations. This is discussed briefly here and reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=see_link\">",
"     \"Aspirin exacerbated respiratory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"     \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Long-term",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy has been shown in retrospective studies to reduce upper and lower airway and inflammation in some patients, although it is rarely sufficient as monotherapy. In addition, gastrointestinal side effects from daily oral aspirin therapy preclude long-term treatment in some patients. The initial maintenance dose of aspirin has traditionally been 650 mg bid, but studies recommend attempting to lower the dose to 325 mg bid for long-term maintenance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/82\">",
"     82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnostic challenge and desensitization protocols for NSAID reactions\", section on 'Desensitization for pseudoallergy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A topical preparation of intranasal lysine-",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    is available in many countries, although not in the United States. Regular intranasal therapy with this agent is being studied for the purpose of treating CRS with NP in aspirin-intolerant patients, but cannot yet be recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1,83\">",
"     1,83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5648084\">",
"    <span class=\"h3\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;One randomized placebo-controlled trial examined the effect of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36390?source=see_link\">",
"     cetirizine",
"    </a>",
"    20 mg once daily for three months as a treatment for 45 patients with residual or recurrent nasal polyps [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/84\">",
"     84",
"    </a>",
"    ]. Both allergic and nonallergic patients were included. The use of topical glucocorticoids was not mentioned except to state that the study group had &ldquo;tried topical steroids unsuccessfully.&rdquo; Inhaled glucocorticoids for asthma were allowed up to 800 micrograms per day. In this study, treatment with cetirizine had no effect on the number or size of nasal polyps or total nasal symptom scores. However, individual symptoms of rhinorrhea, sneezing, and nasal obstruction were improved on cetirizine treatment. Since there are no studies combining treatment with intranasal glucocorticoids plus antihistamines (oral or intranasal), it is unclear whether antihistamines provide any additional benefit in patients already receiving topical glucocorticoids. However, if persistent nasal symptoms are present despite use of intranasal glucocorticoids, antihistamines may be worth trying.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Refractory disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Options for treatment of CRS with NP that does not respond to the above measures include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38629?source=see_link\">",
"     omalizumab",
"    </a>",
"    and, in the setting of a clinical trial, mepolizumab.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H983890166\">",
"    <span class=\"h4\">",
"     Omalizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38629?source=see_link\">",
"     omalizumab",
"    </a>",
"    (an anti-IgE monoclonal antibody) was studied in a small randomized trial of 24 patients with CRS with NP and comorbid asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/85\">",
"     85",
"    </a>",
"    ]. Both allergic and nonallergic patients were included. Subjects received four to eight subcutaneous doses of omalizumab (n = 16) or placebo (n = 8) based on standard omalizumab dosing guidelines (based on serum IgE level and body mass). Omalizumab treatment was associated with a significant decrease in total nasal endoscopic NP scores after 16 weeks compared to placebo. This was confirmed by means of sinus CT scoring (Lund-Mackay score) and was irrespective of the presence of allergy. Omalizumab also improved airway symptoms (nasal congestion, anterior rhinorrhea, loss of sense of smell, wheezing, and dyspnea) and quality of life scores. Presently, omalizumab is only approved by the US Food and Drug Administration for treatment of moderate to severe asthma, and omalizumab treatment should only be considered if the patient has incomplete control of asthma despite appropriate treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/46/17130?source=see_link\">",
"     \"Anti-IgE therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H983890174\">",
"    <span class=\"h4\">",
"     Mepolizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mepolizumab (an anti-interleukin 5 [IL-5] monoclonal antibody preparation) was shown in a small randomized trial to reduce the mass of polyp tissue significantly, although follow-up was relatively brief [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/86\">",
"     86",
"    </a>",
"    ]. IL-5 promotes eosinophil differentiation and survival, and blocking it results in reduced tissue eosinophilia. The utility and practicality of this therapy requires further study. Anti-IL-5 therapy has also been studied in asthma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33354?source=see_link&amp;anchor=H20#H20\">",
"     \"Alternative and experimental agents for the treatment of asthma\", section on 'Anti-IL-5 antibodies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Allergic fungal rhinosinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of AFRS is usually made based upon the finding of allergic mucin containing fungal hyphae at the time of sinus surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AFRS usually require surgery to remove inspissated mucus and maximize sinus ventilation and drainage. The removed material should be cultured for fungus. If a specific fungal species is detected, evidence of fungal-specific IgE against this organism should be sought with allergen skin testing or fungus-specific IgE immunoassays. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link&amp;anchor=H39#H39\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Oral and topical glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AFRS should receive oral glucocorticoids following surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/87\">",
"     87",
"    </a>",
"    ]. In a retrospective series of 67 post-surgical patients, protracted courses of oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    delayed the need for repeat surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/88\">",
"     88",
"    </a>",
"    ]. Prednisone is usually started at 0.5 mg per kilogram daily and tapered over a few weeks to approximately 10 mg daily. Thereafter, the dose is slowly reduced by 1 to 2.5 mg per week to the lowest possible dose necessary to maintain control of sinus symptoms.",
"   </p>",
"   <p>",
"    As soon as the sinus mucosa has healed following sinus surgery, topical glucocorticoid instillations with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    are begun, as described above. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Nasal glucocorticoid instillations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There are no controlled studies evaluating this approach, although it has been highly effective in the author's experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Controversial treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapies of unproven benefit in the treatment of AFRS include systemic and topical antifungal therapy and immunotherapy for fungal allergy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Topical antifungal agents",
"      </strong>",
"      - Clinical studies of topical antifungal agents have yielded conflicting results treating mixed populations of CRS patients with and without nasal polyps. Thus, topical antifungals are not recommended by published guidelines [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1,17\">",
"       1,17",
"      </a>",
"      ]. However, in the author's experience, topical antifungal treatment has been beneficial in a subset of patients, and a therapeutic trial of one of these therapies could be considered for those who have persistent mucosal thickening and mucus production, no evidence of bacterial infection, and who have failed a trial of topical glucocorticoid irrigations.",
"     </li>",
"     <li>",
"      <strong>",
"       Oral antifungal agents",
"      </strong>",
"      - If moderate doses of oral glucocorticoids have failed to control the symptoms of AFRS, the author favors a trial of oral antifungal therapy, although most guidelines do not recommend this and there are no trials demonstrating benefit [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1,39\">",
"       1,39",
"      </a>",
"      ]. Despite the lack of data, the author has administered oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/15/20730?source=see_link\">",
"       itraconazole",
"      </a>",
"      to adults at a dose of 200 mg twice daily for three months with monitoring of AST and ALT levels monthly during treatment. Patients who appeared to respond to oral antifungals were treated thereafter with an antifungal rinse of either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      or itraconazole.",
"     </li>",
"     <li>",
"      <strong>",
"       Immunotherapy for fungal allergy -",
"      </strong>",
"      Fungal immunotherapy, using a mixture of fungal allergens based on the results of skin testing or in vitro testing, has been shown to be safe, with evidence for reduced rates of disease recurrence in treated patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/89-91\">",
"       89-91",
"      </a>",
"      ]. However, the magnitude of effect relative to glucocorticoids is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CRS is an inflammatory disorder of the sinonasal mucosa, and underlying structural abnormalities, such as septal deviation, do not occur with higher frequency in patients with CRS compared to controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/89\">",
"     89",
"    </a>",
"    ]. Thus, surgery should not be the first intervention in most cases, with the possible exception of allergic fungal rhinosinusitis, as previously discussed. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Allergic fungal rhinosinusitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Functional endoscopic sinus surgery, known by the acronym FESS, is intended to restore physiologic sinus ventilation and drainage, which can facilitate the gradual resolution of mucosal disease. However, because FESS does not directly treat the underlying inflammatory disorder, sinus surgery MUST be followed by medical management to control inflammatory processes, or symptoms will invariably return [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/92\">",
"     92",
"    </a>",
"    ]. This is particularly true for surgical polypectomy; polyps usually reaccumulate within a few years without medical maintenance therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/92,93\">",
"     92,93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Indications for surgical intervention include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Restoration of sinus ventilation (ie, restoration of sinus ostial patency and removal of material from opacified sinuses)",
"     </li>",
"     <li>",
"      Debulking of severe polyposis (see",
"      <a class=\"local\" href=\"#H144997\">",
"       'Surgery for glucocorticoid failure'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Confirming the presence of allergic mucin in the diagnosis of AFRS (see",
"      <a class=\"local\" href=\"#H29\">",
"       'Surgery'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Failure of intensive medical treatment",
"     </li>",
"     <li>",
"      Bony erosion or extension of disease beyond the sinus cavities",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Efficacy of surgery for CRS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2006 systematic review of functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis concluded that it was safe, although the procedures encompassed by that term did not clearly confer additional benefit over medical management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/94\">",
"     94",
"    </a>",
"    ]. However, this was based upon just three randomized trials.",
"   </p>",
"   <p>",
"    One of the most comprehensive studies summarized outcomes of 120 consecutive patients with a mean follow-up of 18 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/95\">",
"     95",
"    </a>",
"    ]. Nearly all patients (98 percent) reported improvement in their CRS symptoms at the time of final follow-up visit (85, 13, and 2 percent were markedly, mildly, and not improved respectively). However, 45 percent of the operated sinus cavities were endoscopically abnormal at the end of the study. The phenotype of CRS appeared to influence surgical outcome, as patients with advanced polypoid changes preoperatively had a much higher rate of recurrence of disease and relapse after surgery. In a subsequent survey of 72 patients from the original cohort with an average follow-up of 7.8 years postoperatively, 98 percent of the patients reported sustained subjective improvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is some evidence that medical management results in better long-term outcomes in patients with both asthma and CRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/7,97\">",
"     7,97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 2011 systematic review of functional endoscopic balloon dilation of sinus ostia for CRS identified one study of 34 patients that met inclusion criteria. This review concluded that there is no convincing evidence supporting the use of endoscopic balloon sinus ostial dilation compared to conventional surgical modalities in the management of CRS refractory to medical treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/4/30794/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     TREATING EXACERBATIONS OF CRS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exacerbations of CRS may be precipitated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Discontinuation or reduction of medications",
"     </li>",
"     <li>",
"      Acute viral upper respiratory tract infections",
"     </li>",
"     <li>",
"      Heavy exposure to allergens",
"     </li>",
"     <li>",
"      Exposure to noxious inhalants",
"     </li>",
"     <li>",
"      Worsening of inflammation secondary to bacterial infection or (perhaps) fungal colonization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A bacterial infection should be suspected if the patient has increased symptoms persisting greater than 7 to 10 days, purulent nasal discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased facial pain or pressure. However, the frequency of bacterial infection during acute exacerbations of CRS remains unknown and largely unstudied. The situation is even more complex in patients who have had Staphylococcus aureus, gram-negative rod or drug-resistant bacterial infections in the past.",
"   </p>",
"   <p>",
"    In patients suspected of having uncomplicated bacterial infection, acute exacerbations of CRS are treated similarly to episodes of acute bacterial rhinosinusitis with a 10- to 14-day course of antibiotics. Repeated use of the same agent should be avoided, as there is risk of promoting a drug-resistant bacterial infection and perhaps greater fungal colonization. A culture from the sinus ostium should be obtained if an infection with Staphylococcus aureus, gram-negative rods or drug-resistant bacteria is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link\">",
"     \"Microbiology and antibiotic management of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/18/29985?source=see_link\">",
"       \"Patient information: Nasal polyps (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/37/14930?source=see_link\">",
"       \"Patient information: Chronic sinusitis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/18/16674?source=see_link\">",
"       \"Patient information: Rinsing out your nose with salt water (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/58/42915?source=see_link\">",
"       \"Patient information: Chronic rhinosinusitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic rhinosinusitis (CRS) is an inflammatory condition of the paranasal sinuses and linings of the nasal passages that lasts 12 weeks or longer despite attempts at medical treatment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In most cases, the disorder cannot be cured and the goal of therapy is to reduce symptoms and improve quality of life. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Goals of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple therapies are utilized in the management of CRS, including intranasal saline, topical and systemic glucocorticoids, antibiotics, and antileukotriene agents. These are combined in various ways to manage specific subtypes of CRS. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Overview of medical therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Without nasal polyposis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with untreated CRS without NP, we recommend oral glucocorticoids PLUS oral antibiotics (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). A typical regimen includes",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (in adults, 20 mg twice daily for five days, followed by 20 mg daily for five days) PLUS three to four weeks of an antibiotic. One or more adjunctive therapies (intranasal glucocorticoids",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      intranasal saline) are usually administered concomitantly. Antibiotics may be extended for up to six weeks (or seven days after symptoms have cleared), in patients with colored secretions that are improving gradually but have not cleared. (See",
"      <a class=\"local\" href=\"#H1813323\">",
"       'Option 1: Intensive treatment including oral glucocorticoids'",
"      </a>",
"      above.) Empiric antibiotic regimens for CRS are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link\">",
"       \"Microbiology and antibiotic management of chronic rhinosinusitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For maintenance therapy of CRS without NP, we recommend topical glucocorticoid nasal sprays (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). For patients with persistent or increasing symptoms despite consistent use of glucocorticoid sprays, we recommend changing to glucocorticoid instillations (",
"      <a class=\"graphic graphic_figure graphicRef78384 \" href=\"mobipreview.htm?36/41/37526\">",
"       figure 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Maintenance treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with underlying allergic rhinitis who have sneezing or nasal pruritus may benefit from additional therapies targeting that condition, including nonsedating second-generation antihistamines, antileukotriene agents (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"       montelukast",
"      </a>",
"      ),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      allergen immunotherapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link\">",
"       \"Pharmacotherapy of allergic rhinitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     With nasal polyposis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with CRS with NP who have nasal blockage or an impaired sense of smell, we recommend a course of oral glucocorticoids initially to shrink nasal polyps (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). A typical adult regimen is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      20 mg twice daily for five days, 10 mg twice daily for five days and then 10 mg daily for five days. Very severe polyps may not respond adequately and may require subsequent surgical debulking. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Oral glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with nasal patency and an intact sense of smell, and for maintenance therapy after oral glucocorticoids, we recommend topical glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We advise patients to use nasal sprays initially, but if symptoms worsen despite consistent use, we change this to nasal instillations (",
"      <a class=\"graphic graphic_figure graphicRef78384 \" href=\"mobipreview.htm?36/41/37526\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Topical glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest a trial of an antileukotriene agent (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"       montelukast",
"      </a>",
"      ), in addition to the measures above (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Antileukotriene agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      desensitization and daily aspirin therapy for patients with the combination of CRS with NP, asthma, and aspirin intolerance, provided they have no contraindications to aspirin therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This intervention requires access to an allergy specialist with experience in drug desensitizations. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Aspirin desensitization and therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Allergic fungal disease",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with AFRS usually have severe CRS with or without NP that is refractory to medical therapy and undergo sinus surgery to remove inspissated mucus, following which the diagnosis is made. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For post-surgical patients, we suggest a prolonged course of oral glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       Prednisone",
"      </a>",
"      is usually started at 0.5 mg per kilogram daily and slowly reduced to the lowest possible dose necessary to maintain control of sinus symptoms. In addition, we suggest that patients initiate glucocorticoid nasal instillations as soon as the nasal mucosa is healed after surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Oral and topical glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unproven therapies include oral antifungal agents and antifungal immunotherapy. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Controversial treatments'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/1\">",
"      Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008; 38:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/2\">",
"      Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/3\">",
"      Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007; 45:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/4\">",
"      Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/5\">",
"      Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/6\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/7\">",
"      Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004; 114:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/8\">",
"      Bassiouni A, Naidoo Y, Wormald PJ. Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease? Laryngoscope 2012; 122:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/9\">",
"      Mafee MF. Imaging of paranasal sinuses and rhinosinusitis. Clin Allergy Immunol 2007; 20:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/10\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006; 118:S17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/11\">",
"      Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007; :CD006394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/12\">",
"      Adappa ND, Wei CC, Palmer JN. Nasal irrigation with or without drugs: the evidence. Curr Opin Otolaryngol Head Neck Surg 2012; 20:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/13\">",
"      Pynnonen MA, Mukerji SS, Kim HM, et al. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg 2007; 133:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/14\">",
"      Wormald PJ, Cain T, Oates L, et al. A comparative study of three methods of nasal irrigation. Laryngoscope 2004; 114:2224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/15\">",
"      Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008; 22:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/16\">",
"      Isaacs S, Fakhri S, Luong A, et al. The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects. Am J Rhinol Allergy 2011; 25:e27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/17\">",
"      Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/18\">",
"      Ben&iacute;tez P, Alobid I, de Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 2006; 116:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/19\">",
"      Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001; 39:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/20\">",
"      Lavigne F, Cameron L, Renzi PM, et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002; 112:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/21\">",
"      Lund VJ, Black JH, Szab&oacute; LZ, et al. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 2004; 42:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/22\">",
"      Snidvongs K, Kalish L, Sacks R, et al. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev 2011; :CD009274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/23\">",
"      Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J Pharm Pharmacol 1985; 37:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/24\">",
"      Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol 2005; 115:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/25\">",
"      Hamilos DL. Approach to the evaluation and medical management of chronic rhinosinusitis. Clin Allergy Immunol 2007; 20:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/26\">",
"      Harvey RJ, Debnath N, Srubiski A, et al. Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg 2009; 141:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/27\">",
"      Rotenberg BW, Zhang I, Arra I, Payton KB. Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial. Laryngoscope 2011; 121:2702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/28\">",
"      Sachanandani NS, Piccirillo JF, Kramper MA, et al. The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2009; 135:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/29\">",
"      Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J 2002; 81:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/30\">",
"      Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg 2002; 127:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/31\">",
"      Lim M, Citardi MJ, Leong JL. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol 2008; 22:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/32\">",
"      Jervis-Bardy J, Boase S, Psaltis A, et al. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope 2012; 122:2148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/33\">",
"      Elliott KA, Stringer SP. Evidence-based recommendations for antimicrobial nasal washes in chronic rhinosinusitis. Am J Rhinol 2006; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/34\">",
"      Whatley WS, Chandra RK, MacDonald CB. Systemic absorption of gentamicin nasal irrigations. Am J Rhinol 2006; 20:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/35\">",
"      Cheng AG, Johnston PR, Luz J, et al. Sensorineural hearing loss in patients with cystic fibrosis. Otolaryngol Head Neck Surg 2009; 141:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/36\">",
"      Kieff DA, Busaba NY. Efficacy of montelukast in the treatment of nasal polyposis. Ann Otol Rhinol Laryngol 2005; 114:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/37\">",
"      Mostafa BE, Abdel Hay H, Mohammed HE, Yamani M. Role of leukotriene inhibitors in the postoperative management of nasal polyps. ORL J Otorhinolaryngol Relat Spec 2005; 67:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/38\">",
"      Weschta M, Rimek D, Formanek M, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004; 113:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/39\">",
"      Kennedy DW, Kuhn FA, Hamilos DL, et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005; 115:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/40\">",
"      Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005; 115:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/41\">",
"      Ebbens FA, Scadding GK, Badia L, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006; 118:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/42\">",
"      Helbling A, Baumann A, H&auml;nni C, Caversaccio M. Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 2006; 120:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/43\">",
"      Weschta M, Rimek D, Formanek M, et al. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006; 132:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/44\">",
"      Sacks PL, Harvey RJ, Rimmer J, et al. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011; :CD008263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/45\">",
"      Sacks PL 4th, Harvey RJ, Rimmer J, et al. Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy 2012; 26:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/46\">",
"      Rotenberg BW, Bertens KA. Use of complementary and alternative medical therapies for chronic rhinosinusitis: a canadian perspective. J Otolaryngol Head Neck Surg 2010; 39:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/47\">",
"      Yakirevitch A, Bedrin L, Migirov L, et al. Use of alternative medicine in Israeli chronic rhinosinusitis patients. J Otolaryngol Head Neck Surg 2009; 38:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/48\">",
"      Suh JD, Wu AW, Taw MB, et al. Treatment of recalcitrant chronic rhinosinusitis with integrative East-West medicine: a pilot study. Arch Otolaryngol Head Neck Surg 2012; 138:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/49\">",
"      Helms S, Miller A. Natural treatment of chronic rhinosinusitis. Altern Med Rev 2006; 11:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/50\">",
"      Friedman M, Hamilton C, Samuelson CG, et al. Dead Sea salt irrigations vs saline irrigations with nasal steroids for symptomatic treatment of chronic rhinosinusitis: a randomized, prospective double-blind study. Int Forum Allergy Rhinol 2012; 2:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/51\">",
"      Jiang RS, Wu SH, Tsai CC, et al. Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps. Am J Rhinol Allergy 2012; 26:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/52\">",
"      Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011; 86:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/53\">",
"      Cherry WB, Li JT. Chronic rhinosinusitis in adults. Am J Med 2008; 121:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/54\">",
"      Ozturk F, Bakirtas A, Ileri F, Turktas I. Efficacy and tolerability of systemic methylprednisolone in children and adolescents with chronic rhinosinusitis: a double-blind, placebo-controlled randomized trial. J Allergy Clin Immunol 2011; 128:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/55\">",
"      Subramanian HN, Schechtman KB, Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol 2002; 16:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/56\">",
"      Skorpinski EW, Vannelli PM, Yousef E, et al. Radiologic outcomes in children with chronic rhinosinusitis and ostiomeatal complex obstruction after medical management. Ann Allergy Asthma Immunol 2008; 100:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/57\">",
"      Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011; 66:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/58\">",
"      Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/59\">",
"      Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996; 525:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/60\">",
"      Tatar E&Ccedil;, Tatar I, Ocal B, et al. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. Otolaryngol Head Neck Surg 2012; 146:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/61\">",
"      Zeng M, Long XB, Cui YH, Liu Z. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. Am J Rhinol Allergy 2011; 25:e203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/62\">",
"      Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012; :3 p preceding table of contents, 1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/63\">",
"      Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs 2007; 67:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/64\">",
"      Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database Syst Rev 2011; :CD005232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/65\">",
"      Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology 2006; 44:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/66\">",
"      Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 2006; 118:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/67\">",
"      Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/68\">",
"      Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med 2011; 154:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/69\">",
"      Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol 2012; 129:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/70\">",
"      Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P. Pharmacological management of nasal polyposis. Drugs 2005; 65:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/71\">",
"      Small CB, Hernandez J, Reyes A, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 2005; 116:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/72\">",
"      Stj&auml;rne P, Olsson P, Alenius M. Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 2009; 135:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/73\">",
"      Dijkstra MD, Ebbens FA, Poublon RM, Fokkens WJ. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy 2004; 34:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/74\">",
"      Pauli C, Fintelmann R, Klemens C, et al. [Polyposis nasi--improvement in quality of life by the influence of leukotrien receptor antagonists]. Laryngorhinootologie 2007; 86:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/75\">",
"      Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001; 31:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/76\">",
"      Stewart RA, Ram B, Hamilton G, et al. Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. Otolaryngol Head Neck Surg 2008; 139:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/77\">",
"      Micheletto C, Tognella S, Visconti M, et al. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo. Allergy 2004; 59:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/78\">",
"      Lumry WR, Curd JG, Zeiger RS, et al. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983; 71:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/79\">",
"      Schapowal AG, Simon HU, Schmitz-Schumann M. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis. Acta Otorhinolaryngol Belg 1995; 49:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/80\">",
"      Gosepath J, Schaefer D, Amedee RG, Mann WJ. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001; 127:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/81\">",
"      Rozsasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008; 63:1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/82\">",
"      Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007; 119:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/83\">",
"      Ogata N, Darby Y, Scadding G. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. J Laryngol Otol 2007; 121:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/84\">",
"      Haye R, Aanesen JP, Burtin B, et al. The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998; 112:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/85\">",
"      Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/86\">",
"      Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011; 128:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/87\">",
"      Ikram M, Abbas A, Suhail A, et al. Management of allergic fungal sinusitis with postoperative oral and nasal steroids: a controlled study. Ear Nose Throat J 2009; 88:E8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/88\">",
"      Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol 1998; 102:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/89\">",
"      Bassichis BA, Marple BF, Mabry RL, et al. Use of immunotherapy in previously treated patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 2001; 125:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/90\">",
"      Greenhaw B, deShazo RD, Arnold J, Wright L. Fungal immunotherapy in patients with allergic fungal sinusitis. Ann Allergy Asthma Immunol 2011; 107:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/91\">",
"      Hall AG, deShazo RD. Immunotherapy for allergic fungal sinusitis. Curr Opin Allergy Clin Immunol 2012; 12:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/92\">",
"      Gosepath J, Pogodsky T, Mann WJ. Characteristics of recurrent chronic rhinosinusitis after previous surgical therapy. Acta Otolaryngol 2008; 128:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/93\">",
"      Li Y, Zhang GH, Liu X, et al. Clinical prognostic factors of chronic rhinosinusitis after endoscopic sinus surgery. ORL J Otorhinolaryngol Relat Spec 2008; 70:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/94\">",
"      Khalil HS, Nunez DA. Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev 2006; :CD004458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/95\">",
"      Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992; 102:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/96\">",
"      Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/97\">",
"      Senior BA, Kennedy DW, Tanabodee J, et al. Long-term impact of functional endoscopic sinus surgery on asthma. Otolaryngol Head Neck Surg 1999; 121:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/4/30794/abstract/98\">",
"      Ahmed J, Pal S, Hopkins C, Jayaraj S. Functional endoscopic balloon dilation of sinus ostia for chronic rhinosinusitis. Cochrane Database Syst Rev 2011; :CD008515.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7534 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.65.114.212-1237D62C13-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30794=[""].join("\n");
var outline_f30_4_30794=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GOALS OF THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H97421985\">",
"      REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVERVIEW OF MEDICAL THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nasal saline",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H97421700\">",
"      - Surfactants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Intranasal glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Nasal sprays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Nasal glucocorticoid instillations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Oral glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Antimicrobials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40395549\">",
"      Topical antimicrobials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Antileukotriene agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H97421799\">",
"      Unproven therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      THERAPY FOR SPECIFIC TYPES OF CRS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1198365\">",
"      Guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CRS without nasal polyposis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24297064\">",
"      - Intensive medical management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1813323\">",
"      Option 1: Intensive treatment including oral glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20471416\">",
"      Option 2: Intensive treatment including long-term macrolides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9622221\">",
"      Incomplete response",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Maintenance treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Treatment of underlying allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27882904\">",
"      - Adjunctive therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      CRS with nasal polyposis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Oral glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H144997\">",
"      Surgery for glucocorticoid failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Topical glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Antileukotrienes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Aspirin desensitization and therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5648084\">",
"      - Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Refractory disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H983890166\">",
"      Omalizumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H983890174\">",
"      Mepolizumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Allergic fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Oral and topical glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Controversial treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      INDICATIONS FOR SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Efficacy of surgery for CRS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      TREATING EXACERBATIONS OF CRS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Without nasal polyposis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      With nasal polyposis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Allergic fungal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/7534\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7534|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/41/37526\" title=\"figure 1\">",
"      Medication positions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7534|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/33/43548\" title=\"table 1\">",
"      Nasal irrigation instruct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/18/16685\" title=\"table 2\">",
"      Glucocorticoid nasal sprays",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/1/30746?source=related_link\">",
"      Agents affecting the 5-lipoxygenase pathway in the treatment of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/48/34569?source=related_link\">",
"      Allergen avoidance in the treatment of asthma and allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33354?source=related_link\">",
"      Alternative and experimental agents for the treatment of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/46/17130?source=related_link\">",
"      Anti-IgE therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=related_link\">",
"      Aspirin exacerbated respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=related_link\">",
"      Diagnostic challenge and desensitization protocols for NSAID reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=related_link\">",
"      Microbiology and antibiotic management of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/58/42915?source=related_link\">",
"      Patient information: Chronic rhinosinusitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/37/14930?source=related_link\">",
"      Patient information: Chronic sinusitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/18/29985?source=related_link\">",
"      Patient information: Nasal polyps (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/18/16674?source=related_link\">",
"      Patient information: Rinsing out your nose with salt water (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/8/39049?source=related_link\">",
"      Subcutaneous immunotherapy for allergic disease: Indications and efficacy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_4_30795="Cost effectiveness OI Rx in HIV";
var content_f30_4_30795=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cost-effectiveness of preventing AIDS-related opportunistic infections",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Infection",
"       </td>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cost per year for the drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cost per QALY*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumocystis carinii pneumonia",
"       </td>",
"       <td>",
"        Trimethoprim-sulfamethoxazole",
"       </td>",
"       <td>",
"        $25",
"       </td>",
"       <td>",
"        $16,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Mycobacterium avium complex",
"       </td>",
"       <td>",
"        Azithromycin",
"       </td>",
"       <td>",
"        $1450",
"       </td>",
"       <td>",
"        $35,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clarithromycin",
"       </td>",
"       <td>",
"        $2455",
"       </td>",
"       <td>",
"        $58,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rifabutin",
"       </td>",
"       <td>",
"        $2140",
"       </td>",
"       <td>",
"        $74,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fungal infections",
"       </td>",
"       <td>",
"        Fluconazole",
"       </td>",
"       <td>",
"        $2472",
"       </td>",
"       <td>",
"        $100,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytomegalovirus",
"       </td>",
"       <td>",
"        Oral ganciclovir",
"       </td>",
"       <td>",
"        $15,600",
"       </td>",
"       <td>",
"        $314,000",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     QALY: quality-adjusted life-year saved.",
"    </div>",
"    <div class=\"reference\">",
"     From Freedberg, KA, Scharfstein, JA, Seage, GA, et al, JAMA 1998; 279:130.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30795=[""].join("\n");
var outline_f30_4_30795=null;
var title_f30_4_30796="Causes of third nerve palsy";
var content_f30_4_30796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F56375&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F56375&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Acquired third nerve lesions: most common causes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Location of the lesion",
"       </td>",
"       <td class=\"subtitle1\">",
"        Associated symptoms/signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Most common causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nucleus",
"       </td>",
"       <td>",
"        Complete ipsilateral third plus contralateral ptosis and contralateral superior rectus weakness",
"       </td>",
"       <td>",
"        <p>",
"         Infarction",
"        </p>",
"        <p>",
"         Hemorrhage",
"        </p>",
"        <p>",
"         Tumor",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fascicles",
"       </td>",
"       <td>",
"        <p>",
"         Contralateral hemiparesis (Weber's syndrome)",
"        </p>",
"        <p>",
"         Contralateral tremor (Benedikt's syndrome)",
"        </p>",
"        <p>",
"         Ipsilateral ataxia (Nothnagel's syndrome)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Infarction",
"        </p>",
"        <p>",
"         Hemorrhage",
"        </p>",
"        <p>",
"         Tumor",
"        </p>",
"        <p>",
"         Demyelination",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subarachnoid space",
"       </td>",
"       <td>",
"        <p>",
"         Typically isolated",
"        </p>",
"        <p>",
"         May present with headaches or orbital pain",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         ICA/Pcom A/Basilar/PCA Aneurysm",
"        </p>",
"        <p>",
"         Microvascular (ischemic)",
"        </p>",
"        <p>",
"         Tumor (pituitary, carcinomatous meningitis)",
"        </p>",
"        <p>",
"         Meningitis",
"        </p>",
"        <p>",
"         Herniation",
"        </p>",
"        <p>",
"         Trauma",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cavernous sinus",
"       </td>",
"       <td>",
"        <p>",
"         Cranial nerves IV, VI, V1, V2",
"        </p>",
"        <p>",
"         Oculosympathetic dysfunction (Horner)",
"        </p>",
"        <p>",
"         Pain may be prominent",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Tumor",
"        </p>",
"        <p>",
"         Inflammation",
"        </p>",
"        <p>",
"         Carotid aneurysm",
"        </p>",
"        <p>",
"         Microvascular (ischemic)",
"        </p>",
"        <p>",
"         Thrombosis",
"        </p>",
"        <p>",
"         Arteriovenous fistula",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orbital apex",
"       </td>",
"       <td>",
"        <p>",
"         Proptosis",
"        </p>",
"        <p>",
"         Visual loss",
"        </p>",
"        <p>",
"         Cranial nerves IV, VI, V1, V2",
"        </p>",
"        <p>",
"         Oculosympathetic dysfunction (Horner)",
"        </p>",
"        <p>",
"         Pain may be prominent",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Trauma",
"        </p>",
"        <p>",
"         Tumor",
"        </p>",
"        <p>",
"         Inflammation",
"        </p>",
"        <p>",
"         Infection (fungus)",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ICA: internal carotid artery; Pcom A: posterior communicating artery; PCA: posterior cerebral artery.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Biousse V, Newman NJ. Third Nerve Palsies. Semin Neurol 2000; 20:55. Copyright &copy; 2000 Theime Medical Publishers.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30796=[""].join("\n");
var outline_f30_4_30796=null;
var title_f30_4_30797="BAL fluid in non smokers";
var content_f30_4_30797=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expected values of BAL fluid constituents in healthy never smokers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean &plusmn; SEM",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile*",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent recovery of lavagate",
"       </td>",
"       <td>",
"        63.4 &plusmn; 1.1",
"       </td>",
"       <td>",
"        40.8",
"       </td>",
"       <td>",
"        80.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells, 10",
"        <sup>",
"         6&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        18.1 &plusmn; 1.9",
"       </td>",
"       <td>",
"        5.2",
"       </td>",
"       <td>",
"        33.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        12.9 &plusmn; 2.0",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"       <td>",
"        35.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        85.2 &plusmn; 1.6",
"       </td>",
"       <td>",
"        54.6",
"       </td>",
"       <td>",
"        97.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        9.9 &plusmn; 0.8",
"       </td>",
"       <td>",
"        2.7",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        11.81 &plusmn; 1.1",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"       <td>",
"        34.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.49 &plusmn; 0.25",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        4.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.7",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.2 &plusmn; 1.1",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.19 &plusmn; 0.06",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.02 &plusmn; 0.007",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        70.27 &plusmn; 3.56",
"       </td>",
"       <td>",
"        25.6",
"       </td>",
"       <td>",
"        94.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-helper cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        44.4 &plusmn; 3.71",
"       </td>",
"       <td>",
"        7.6",
"       </td>",
"       <td>",
"        83.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-suppressor cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        20.73 &plusmn; 2.17",
"       </td>",
"       <td>",
"        6.6",
"       </td>",
"       <td>",
"        49.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helper/suppressor ratio",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        2.61 &plusmn; 0.29",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        6.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        3.23 &plusmn; 0.85",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        17.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        5.92 &plusmn; 0.48",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        14.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        6.22 &plusmn; 0.60",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"       <td>",
"        15.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.20 &plusmn; 0.019",
"       </td>",
"       <td>",
"        0.03",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        34.23 &plusmn; 1.67",
"       </td>",
"       <td>",
"        15.7",
"       </td>",
"       <td>",
"        59.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total protein, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        78.24 &plusmn; 4.04",
"       </td>",
"       <td>",
"        39.5",
"       </td>",
"       <td>",
"        140.7",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"     <br>",
"      * 5th percentile of the study population.",
"      <br>",
"       &bull; 95th percentile of the study population.",
"       <br>",
"        &Delta; n = 77.",
"        <br>",
"         &loz; n = 30.",
"         <br>",
"          &sect; n = 76.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: BAL Cooperative Group. Am Rev Respir Dis 1990; 141:S169 (BAL Cooperative Group, 1990 #261).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30797=[""].join("\n");
var outline_f30_4_30797=null;
var title_f30_4_30798="Natal cleft";
var content_f30_4_30798=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F87078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F87078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Natal cleft",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This image shows the location of the natal cleft, also called the intergluteal cleft. It extends from just below the sacrum to the perineum and ends superior to the anus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30798=[""].join("\n");
var outline_f30_4_30798=null;
var title_f30_4_30799="ST segment resolution and mortality";
var content_f30_4_30799=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73003%7ECARD%2F75462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73003%7ECARD%2F75462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mortality after thrombolytic therapy is lower with complete ST segment resolution",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 316px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In four studies of thrombolytic therapy for an acute myocardial infarction, the degree of ST segment resolution at 180 min after administration of therapy was associated with 35-day mortality. All studies found statistically significant mortality differences between the three groups of ST resolution.",
"    <div class=\"footnotes\">",
"     GUSTO-III: Global Use of Strategies to Open Occluded Coronary Arteries study; HIT-4: Hirudin for Improvement of Thrombolysis (HIT)-4 study; INJECT: International Joint Efficacy Comparison of Thrombolytics study; ISAM: Intravenous Streptokinase in Acute Myocardial Infarction.",
"    </div>",
"    <div class=\"reference\">",
"     Data from de Lemos JA, Braunwald E. J Am Coll Cardiol 2001; 38:1283.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 516px\">",
"   <div class=\"ttl\">",
"    Prognosis of myocardial infarction in relation to ST changes at 90 minutes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 496px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    All ST changes measured in lead with maximum change at baseline. Persistence of bundle-branch block is prognostic indication for worst outcome except when there is &lt;2 mm change at 90 minutes with an inferior infarction, when it indicates medium prognosis.",
"    <div class=\"footnotes\">",
"     * Baseline ST elevation &gt;4.5 mm.",
"     <br>",
"      &bull; Baseline ST elevation &le;4.5 mm.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Varma C, Brecker S. Lancet 2001; 358:1473, based on data from Schroder K, Wegscheider K, Zeymer U, et al. Lancet 2001; 358:1479. Copyright &copy; 2001, The Lancet Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_4_30799=[""].join("\n");
var outline_f30_4_30799=null;
